syndrome	score	normalized_score
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	2.6278624	100.0
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	2.12746305	80.95793181560799
NAIL-PATELLA SYNDROME	2.0987440399999997	79.86506599432298
FOCAL DERMAL HYPOPLASIA; FDH	2.0169803600000002	76.75365194159329
MEIER-GORLIN SYNDROME 1; MGORS1	1.85510049	70.59351699693256
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	1.63461538	62.203233319979
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	1.55623275	59.220480874493276
CLEIDOCRANIAL DYSPLASIA; CCD	1.5487135999999997	58.93434907398498
RESTRICTIVE DERMOPATHY, LETHAL	1.5	57.08061426656129
PSEUDOACHONDROPLASIA	1.4295622	54.400192338837826
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	1.4087409799999997	53.607866987251676
DYGGVE-MELCHIOR-CLAUSEN DISEASE	1.35857228	51.69876017861513
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	1.3529411	51.48447270298475
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	1.34949596	51.35337223136188
118610 CHONDROCALCINOSIS DUE TO APATITE CRYSTAL DEPOSITION;;FAMILIAL APATITE DISEASE	1.333333	50.73831110791798
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	1.24326239	47.310787277142055
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	1.2268980999999999	46.68806479365129
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	1.21535105	46.24865632234017
COFFIN-SIRIS SYNDROME 1; CSS1	1.20847141	45.98686027091829
#602875 ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDMST. HELENA DYSPLASIA, INCLUDED	1.2	45.66449141324903
DIAPHANOSPONDYLODYSOSTOSIS	1.1475421899999998	43.66827540132998
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	1.08319133	41.21948432307567
MARSHALL-SMITH SYNDROME; MRSHSS	1.07769683	41.01039803301725
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	1.0769231	40.98095471056627
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF	1.0714286	40.77186842050786
TREMOR, HEREDITARY ESSENTIAL, 5; ETM5	1.0667311	40.59311096349641
FRONTOMETAPHYSEAL DYSPLASIA	1.0631499500000001	40.45683480230929
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	1.0588235	40.29219718658024
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	1.05438606	40.1233359859329
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	1.04791755	39.877184969806635
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	1.0454066400000002	39.78163544636127
HALLERMANN-STREIFF SYNDROME; HSS	1.04040825	39.59142799866538
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	1.0398687500000001	39.57089800440084
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	1.0394552700000002	39.55516354280955
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	1.0306364399999999	39.21957405380129
#602111 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE;;SEMD, MISSOURI TYPEMETAPHYSEAL ANADYSPLASIA 1, INCLUDED; MANDP1, INCLUDED	1.025641	39.02947886464679
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS	1.025641	39.02947886464679
THANATOPHORIC DYSPLASIA, TYPE II	1.0254817999999999	39.02342070878596
THANATOPHORIC DYSPLASIA, TYPE I	1.0254817999999999	39.02342070878596
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	1.02072139	38.84226929081218
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	1.0128782900000002	38.543809980309476
YOU-HOOVER-FONG SYNDROME; YHFS	1.01129336	38.483497461663134
C SYNDROME	1.0060642	38.28450835173104
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	1.00515464	38.24989618938952
CREE MENTAL RETARDATION SYNDROME	1.00515464	38.24989618938952
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	1.0	38.05374284437419
EHLERS-DANLOS SYNDROME, TYPE I	1.0	38.05374284437419
HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE	1.0	38.05374284437419
PATELLA, CHONDROMALACIA OF	1.0	38.05374284437419
PARANA HARD-SKIN SYNDROME	1.0	38.05374284437419
ULNA METAPHYSEAL DYSPLASIA SYNDROME	1.0	38.05374284437419
%152800 LYMPHANGIECTASIA, INTESTINAL	1.0	38.05374284437419
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	1.0	38.05374284437419
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	1.0	38.05374284437419
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	1.0	38.05374284437419
259660 OSTEOMALACIA, SCLEROSING, WITH CEREBRAL CALCIFICATION	1.0	38.05374284437419
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	1.0	38.05374284437419
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	1.0	38.05374284437419
TALO-PATELLO-SCAPHOID OSTEOLYSIS, SYNOVITIS, AND SHORT FOURTH METACARPALS	1.0	38.05374284437419
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	1.0	38.05374284437419
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	1.0	38.05374284437419
OMODYSPLASIA 1; OMOD1	1.0	38.05374284437419
YUNIS-VARON SYNDROME	0.95111289	36.19340533202956
DYSOSTEOSCLEROSIS	0.8186710500000001	31.153497610833806
#304150 OCCIPITAL HORN SYNDROME; OHS;;CUTIS LAXA, X-LINKED, FORMERLY;;EHLERS-DANLOS SYNDROME, OCCIPITAL HORN TYPE, FORMERLY;;EDS IX, FORMERLY;;EDS9, FORMERLY	0.79261867	30.162107041829888
TURNPENNY-FRY SYNDROME; TPFS	0.7663166700000001	29.161217497537166
FIBROCHONDROGENESIS 1; FBCG1	0.7478260000000001	28.457578296336976
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.69305057	26.37316816892696
SPONDYLOCOSTAL DYSOSTOSIS 5	0.6810439799999999	25.916272480629114
EXOSTOSES, MULTIPLE, TYPE I	0.6784307	25.81682739552878
EXOSTOSES, MULTIPLE, TYPE II	0.6784307	25.81682739552878
KYPHOMELIC DYSPLASIA	0.6742424	25.657446904373682
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.66271915	25.21894411214225
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.66055879	25.136734328250977
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.642857	24.463114963705863
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.6397768	24.34590182499662
THORACOLARYNGOPELVIC DYSPLASIA	0.6330825999999999	24.09116245964781
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.6282023299999999	23.905449920056693
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.62611359	23.825965545227938
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.62611359	23.825965545227938
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.62611359	23.825965545227938
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.625641	23.807981726897115
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.60752849	23.118732929090957
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.59153642	22.510174809761725
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.58444659	22.240380242131398
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.5811591	22.11527894306795
SPRENGEL DEFORMITY	0.5769231	21.954083288379177
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.56534134	21.51335397165392
WEAVER SYNDROME	0.55340083	21.05897287468324
BASAL CELL NEVUS SYNDROME	0.55329746	21.05503925928542
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.5526557	21.030617889277607
SCLEROSTEOSIS 1; SOST1	0.5526316	21.02970079407506
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.5478187	20.846551935139374
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.54644327	20.794211675618936
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.5343163	20.332735077757494
MEIER-GORLIN SYNDROME 3; MGORS3	0.52917158	20.136959225871184
COFFIN-LOWRY SYNDROME; CLS	0.52543886	19.994915258881132
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.52444116	19.9569490396453
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.5144116599999999	19.575289025787647
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.51065274	19.432248050735076
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.50515464	19.22302476720242
POTOCKI-LUPSKI SYNDROME	0.50357664	19.162975960994
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.50111359	19.069247689681163
CARTILAGE-HAIR HYPOPLASIA; CHH	0.5	19.026871422187096
RAMON SYNDROME	0.5	19.026871422187096
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.5	19.026871422187096
CLEIDORHIZOMELIC SYNDROME	0.5	19.026871422187096
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.5	19.026871422187096
#614135 EPIPHYSEAL DYSPLASIA, MULTIPLE, 6; EDM6	0.5	19.026871422187096
TRICHOHEPATOENTERIC SYNDROME 1	0.5	19.026871422187096
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.5	19.026871422187096
IMMUNODEFICIENCY 36; IMD36	0.5	19.026871422187096
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.5	19.026871422187096
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.5	19.026871422187096
POPLITEAL CYST	0.5	19.026871422187096
#200600 ACHONDROGENESIS, TYPE IA; ACG1A;;ACHONDROGENESIS, HOUSTON-HARRIS TYPE	0.4956619	18.861790480353914
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.49091521	18.681161159731953
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.48797615	18.569318926287767
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.48573790000000006	18.48414513636635
AICARDI SYNDROME; AIC	0.47517379000000004	18.082141211046668
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.47026745000000003	17.8954366103796
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.4633009	17.630333308167124
MORQUIO SYNDROME A	0.4633009	17.630333308167124
Contractural arachnodactyly, congenital	0.44835252999999997	17.061491880244564
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.44459367	16.91845318841656
CRANIOFRONTONASAL SYNDROME; CFNS	0.43746933000000005	16.647345386120673
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.43024074999999995	16.372270861670685
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.4102561	15.611780129735864
CAMPOMELIC DYSPLASIA	0.41020439	15.60981237069338
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA;;FACIOAURICULORADIAL DYSPLASIA	0.4089743	15.563002842157944
RUIJS-AALFS SYNDROME; RJALS	0.39731114	15.119175950765154
COSTOCORACOID LIGAMENT, CONGENITALLY SHORT	0.3921565	14.923022605749829
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.3905522	14.861972986104599
LOEYS-DIETZ SYNDROME 3; LDS3	0.37927435	14.432808582367173
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.36912935	14.046753361210998
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.36912935	14.046753361210998
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.36363629999999997	13.837722249079706
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.36363599999999996	13.837710832956853
CHROMOSOME 1P36 DELETION SYNDROME	0.36174458	13.765735222666148
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.35992839	13.696622395449623
EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2	0.358974	13.660304283816382
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.3589704	13.660167290342143
#610682 OSTEOGENESIS IMPERFECTA, TYPE VII; OI7;;OI, TYPE VII;;OSTEOGENESIS IMPERFECTA, TYPE IIB, FORMERLY; OI2B, FORMERLY	0.34947664	13.298894188675936
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.3480012	13.242748174333633
ANGELMAN SYNDROME	0.34512383999999996	13.133253856822943
OPSISMODYSPLASIA; OPSMD	0.34467839	13.116302817072917
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.34347397999999996	13.070470508653722
NOONAN SYNDROME 6; NS6	0.34265000999999995	13.039115366162243
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.33690964	12.820672802350686
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.33641684000000005	12.80191991787698
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.33638177999999996	12.800585753652852
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.33579605	12.77829653485662
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.33444659	12.726944531037848
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.33444659	12.726944531037848
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.33444659	12.726944531037848
PARAGANGLIOMAS 4	0.333333	12.684568263543783
CHONDRODYSPLASIA, LETHAL, WITH LONG BONE ANGULATION AND MIXED BONE DENSITY	0.333333	12.684568263543783
#604864 OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA	0.333333	12.684568263543783
PARAGANGLIOMAS 3	0.333333	12.684568263543783
KEUTEL SYNDROME; KTLS	0.333333	12.684568263543783
PARAGANGLIOMAS 1	0.333333	12.684568263543783
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.333333	12.684568263543783
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.333333	12.684568263543783
#222600 DIASTROPHIC DYSPLASIA;;DTD;;DDDIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, INCLUDED	0.333333	12.684568263543783
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.333333	12.684568263543783
ANAUXETIC DYSPLASIA 2; ANXD2	0.3269231	12.44064757728563
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.31880145	12.131588396713616
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.30172273	11.481679177722546
SPINOCEREBELLAR ATAXIA 12	0.29376305999999996	11.178783942416464
#615633 SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11	0.29373857999999997	11.177852386791635
BRACHYDACTYLY, TYPE E	0.2833333	10.781892537447927
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.28137914999999997	10.707529815868591
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.27618006000000006	10.509684981983836
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.27172542	10.340169256959571
OTOONYCHOPERONEAL SYNDROME	0.2696078	10.259585890037469
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.26644023	10.139047995815915
HYPOPHOSPHATASIA, INFANTILE	0.26560638999999997	10.10731726288256
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.2635159	10.027766294003825
Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	0.26271945	9.997458390515424
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.2623685	9.98410342946419
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.2617647	9.961126579534758
CYSTINOSIS, NEPHROPATHIC; CTNS	0.2617647	9.961126579534758
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.2614732	9.950033913495623
#605355 NEMALINE MYOPATHY 5; NEM5;;NEMALINE MYOPATHY, AMISH TYPE; ANM;;AMISH NEMALINE MYOPATHY	0.26120485000000004	9.939822191603335
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.25867205	9.843439671727102
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.25246305	9.607163982406384
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.25	9.513435711093548
HYPOPHOSPHATASIA, CHILDHOOD	0.25	9.513435711093548
%169000 PATELLA, FAMILIAL RECURRENT DISLOCATION OF	0.25	9.513435711093548
NOONAN SYNDROME 4; NS4	0.25	9.513435711093548
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.25	9.513435711093548
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.25	9.513435711093548
WIDOW&#39;S PEAK SYNDROME	0.25	9.513435711093548
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.24294868000000003	9.245106593100157
KBG SYNDROME	0.24066569999999998	9.158230659261307
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.24001999000000002	9.133658976969267
#608728 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 RELATED;;SEMD, MATN3-RELATED	0.23333330000000002	8.879205395229217
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.23255982	8.84977158621395
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.22968550000000001	8.740392952081509
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.22847228000000003	8.694225390187858
MICROPHTHALMIA, SYNDROMIC 3	0.22517379	8.568705499953118
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.22474729999999998	8.55247595916742
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.22455841	8.545287987681546
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.22406020000000001	8.526329232459052
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.22207085000000001	8.450627019131595
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.21634192000000002	8.232619790138175
Osteogenesis imperfecta, type IX	0.21477002	8.172803111761102
SCHNECKENBECKEN DYSPLASIA	0.21184540000000002	8.06151037436359
CORNELIA DE LANGE SYNDROME 1	0.21168609	8.055448032591052
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.20961538000000002	7.976649766745777
Pontine tegmental cap dysplasia	0.20727943999999998	7.8877585066858895
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.20683513999999997	7.8708512287401335
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	0.2040708	7.765657745245718
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.2	7.61074856887484
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.2	7.61074856887484
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.2	7.61074856887484
THREE M SYNDROME 2; 3M2	0.19846655	7.552395056910132
DYSTONIA 16; DYT16	0.19452484	7.402398238203036
GENITOPATELLAR SYNDROME; GTPTS	0.18806999000000002	7.156767036204028
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.18803409999999998	7.155401287373341
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.18685179	7.11040996667101
#615503 SHORT RIB-POLYDACTYLY SYNDROME, TYPE VI; SRPS6	0.18659279999999998	7.100554427811743
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.1857466	7.068353350616836
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.18451035	7.021309411025478
HUNTINGTON DISEASE-LIKE 2	0.18265206000000003	6.950594521235207
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.18259949999999997	6.9485944165113045
FRANK-TER HAAR SYNDROME; FTHS	0.18137688999999999	6.902069529972345
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.17878433	6.803412918423735
WAARDENBURG SYNDROME, TYPE 1; WS1	0.1769231	6.7325861506294995
PATELLA APLASIA-HYPOPLASIA	0.1769231	6.7325861506294995
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.17474920000000002	6.649861119060116
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.1737592	6.612187913644184
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.1737592	6.612187913644184
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.1737592	6.612187913644184
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.1737592	6.612187913644184
TREMOR, HEREDITARY ESSENTIAL, 1	0.1704545	6.48643170966638
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.1704545	6.48643170966638
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.16971578	6.458320648752386
FLOATING-HARBOR SYNDROME	0.16915456	6.4369641271932645
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.168856	6.425602801729649
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.16872869	6.420758179728131
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.166667	6.342303158643315
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.166667	6.342303158643315
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.166667	6.342303158643315
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.166667	6.342303158643315
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.166667	6.342303158643315
#608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	0.166667	6.342303158643315
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.166667	6.342303158643315
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.1666667	6.342291742520461
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.16524719	6.288274074015441
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.1641336	6.245897806521375
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.1641336	6.245897806521375
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.16235330999999997	6.178151108672965
OCULOSKELETODENTAL SYNDROME; OCSKD	0.1608269	6.120065495057884
ACRORENAL-MANDIBULAR SYNDROME	0.16063815	6.112882851096009
SPINOCEREBELLAR ATAXIA 27; SCA27	0.15905306	6.052564243850819
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.15808250000000001	6.0156308031957835
KAGAMI-OGATA SYNDROME	0.15641659000000002	5.952236692453913
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.15384620000000002	5.854423732384162
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.15384620000000002	5.854423732384162
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.15384620000000002	5.854423732384162
PELIZAEUS-MERZBACHER DISEASE	0.15315433999999997	5.828095869859851
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.15148328	5.764505782342332
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.15148327999999997	5.764505782342331
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.1511638	5.752348372578411
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.14899571999999997	5.66984481379238
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.14788212999999997	5.627468546298313
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.14638008	5.570309921858922
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.1462183	5.564153587341559
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.14602156	5.556666893974357
#611302 SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2	0.14602156	5.556666893974357
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.14590577999999998	5.552261031627834
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.14404750000000002	5.481546522374992
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.14397058999999998	5.47861980901283
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.14397058999999998	5.47861980901283
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.14285699999999998	5.436243541518763
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.14285699999999998	5.436243541518763
TREMOR, NYSTAGMUS, AND DUODENAL ULCER	0.14285699999999998	5.436243541518763
BRUNNER SYNDROME; BRNRS	0.14285699999999998	5.436243541518763
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.14186964	5.398670797983943
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.1365928	5.197867285593035
CHARGE SYNDROME	0.1357466	5.165666208398126
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.13275035	5.051647681400669
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.1323876	5.037843686183872
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.13150349	5.0041999915977335
CERVICAL RIB	0.12997889999999998	4.946183635794628
MEIER-GORLIN SYNDROME 7	0.12995061	4.945107095409561
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.12921484	4.917108293036956
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.12834406999999998	4.88397223538036
RAPADILINO SYNDROME	0.12746305	4.85044612685961
#200610 ACHONDROGENESIS, TYPE II; ACG2;;ACHONDROGENESIS, LANGER-SALDINO TYPE;;CHONDROGENESIS IMPERFECTA;;ACHONDROGENESIS, TYPE IB, FORMERLYHYPOCHONDROGENESIS, INCLUDED	0.12713020000000003	4.837779938553862
#150250 LARSEN SYNDROME; LRS	0.12588101999999998	4.790243964067524
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.125	4.756717855546774
SPINAL MUSCULAR ATROPHY, TYPE IV	0.125	4.756717855546774
MEIER-GORLIN SYNDROME 2; MGORS2	0.125	4.756717855546774
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.125	4.756717855546774
SPINAL MUSCULAR ATROPHY, TYPE II	0.125	4.756717855546774
ANIRIDIA AND ABSENT PATELLA	0.125	4.756717855546774
PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	0.125	4.756717855546774
DYSTONIA 7, TORSION	0.125	4.756717855546774
#200700 CHONDRODYSPLASIA, GREBE TYPE;;ACHONDROGENESIS, BRAZILIAN;;GREBE CHONDRODYSPLASIA;;GREBE DYSPLASIA;;ACROMESOMELIC DYSPLASIA, GREBE TYPE; AMDG;;ACHONDROGENESIS, TYPE II, FORMERLY	0.125	4.756717855546774
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.125	4.756717855546774
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.1249417	4.754499322338948
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.12447143	4.736603788691522
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.1242424	4.727888339967876
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.12394418000000001	4.716539952776828
ELLIS-VAN CREVELD SYNDROME	0.12378498000000002	4.710481796916003
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.12362640000000001	4.704447234375742
FRYNS SYNDROME; FRNS	0.1233601	4.694313522656285
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.12287569999999999	4.675880289622469
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.12209999999999999	4.646362001298089
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.12041052999999999	4.582071344374803
#192350 VATER ASSOCIATIONVACTERL ASSOCIATION, INCLUDED	0.12040140000000002	4.5817239137026355
NOONAN SYNDROME 2; NS2	0.12040140000000002	4.5817239137026355
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.12027960000000001	4.577088967824191
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.11973352999999999	4.5563089604691625
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.11972960000000002	4.556159409259785
SCARF SYNDROME	0.11924584000000002	4.53775053062139
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.11868745	4.51650170115452
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.11666660000000001	4.4396007949274665
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.11458330000000001	4.360323432459782
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.11432880000000002	4.350638754905889
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.11387477000000001	4.333361214042258
#313400 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT;;SED TARDA, X-LINKED;;SPONDYLOEPIPHYSEAL DYSPLASIA, LATE	0.11263740000000001	4.286274654258914
%300712 CRANIOFACIOSKELETAL SYNDROME	0.11263740000000001	4.286274654258914
#184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK;;SEMD, STRUDWICK TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;;SMED, STRUDWICK TYPE;;SMED, TYPE I;;STRUDWICK SYNDROME;;DAPPLED METAPHYSIS SYNDROME;;SPONDYLOMETAPHYSEAL DYSPLASIA; SMD;;SEMDC	0.11228918000000002	4.273023579925646
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.11222458999999999	4.270565688675327
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.11222458999999999	4.270565688675327
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.11189568999999999	4.258049812653812
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.11111099999999999	4.22818942118126
CAMPTODACTYLY 1; CAMPD1	0.11111099999999999	4.22818942118126
#615034 DYSTONIA 24; DYT24	0.11111099999999999	4.22818942118126
#615040 EPISODIC PAIN SYNDROME, FAMILIAL, 1; FEPS1	0.11111099999999999	4.22818942118126
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.11111099999999999	4.22818942118126
BUERGER DISEASE	0.11111099999999999	4.22818942118126
CLUSTER HEADACHE, FAMILIAL	0.11111099999999999	4.22818942118126
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.11111099999999999	4.22818942118126
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.11111099999999999	4.22818942118126
DYSTONIA 23; DYT23	0.11111099999999999	4.22818942118126
#108721 ATELOSTEOGENESIS, TYPE III; AOIII;;AO3	0.11111099999999999	4.22818942118126
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.11111099999999999	4.22818942118126
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.110989	4.2235468645542475
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.11090838	4.220478971806134
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.11002259	4.186771346932016
MICROPHTHALMIA, SYNDROMIC 1	0.10941403000000001	4.163613361186644
MELNICK-NEEDLES SYNDROME	0.10918370000000001	4.154848442597299
OSTEOGENESIS IMPERFECTA, TYPE X	0.10680189	4.064211657353139
HOLT-ORAM SYNDROME	0.10515464000000001	4.001527629452744
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.10515464000000001	4.001527629452744
ODONTOCHONDRODYSPLASIA; ODCD	0.10506888	3.9982641404664108
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.10294526000000001	3.9174524510872417
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.10267380000000001	3.9071223820547076
INCONTINENTIA PIGMENTI; IP	0.10248756	3.900035252987371
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.10248756	3.900035252987371
KENNERKNECHT SYNDROME	0.10246305	3.8991025557502548
SCHOLTE SYNDROME; SHLTS	0.10111359	3.8477505519314863
OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	0.1	3.80537428443742
BOWEN-CONRADI SYNDROME	0.1	3.80537428443742
#119800 CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/ORMIRROR-IMAGE POLYDACTYLY; CCF	0.1	3.80537428443742
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.1	3.80537428443742
FRASER SYNDROME 2; FRASRS2	0.1	3.80537428443742
CORACOCLAVICULAR JOINT, ANOMALOUS	0.1	3.80537428443742
SPONDYLOSPINAL THORACIC DYSOSTOSIS	0.1	3.80537428443742
METACHONDROMATOSIS	0.1	3.80537428443742
#614205 THREE M SYNDROME 3; 3M3;;3@M SYNDROME 3	0.1	3.80537428443742
LARON SYNDROME	0.1	3.80537428443742
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.1	3.80537428443742
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.1	3.80537428443742
CALCIFICATION OF JOINTS AND ARTERIES; CALJA	0.1	3.80537428443742
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.09827792	3.7398426949599792
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.09804319000000002	3.73091033990212
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.0965309	3.6733620451360007
NOONAN SYNDROME 7; NS7	0.09529427000000001	3.6263036451223627
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.09509800000000002	3.6188348370142975
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0932806	3.5496759647689315
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.09256106	3.5222947746426905
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.09250035	3.5199845319146084
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.09215680000000001	3.506911168560424
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.09107604000000001	3.4657842054439385
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5	0.0909091	3.4594315136134988
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.0909091	3.4594315136134988
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18; CMH18	0.0909091	3.4594315136134988
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.0909091	3.4594315136134988
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.0909091	3.4594315136134988
GLUTAMATE MONOSODIUM SENSITIVITY	0.0909091	3.4594315136134988
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.0909091	3.4594315136134988
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.0909091	3.4594315136134988
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10	0.0909091	3.4594315136134988
Yao syndrome	0.0909091	3.4594315136134988
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13; CMH13	0.0909091	3.4594315136134988
#134610 FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT;;FMF, AUTOSOMAL DOMINANT	0.0909091	3.4594315136134988
FIBROCHONDROGENESIS 2; FBCG2	0.0894928	3.4055359976230104
DESBUQUOIS DYSPLASIA 2; DBQD2	0.08889569	3.3828137272332066
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.08848794000000001	3.367297313588413
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.08837525	3.3630090373072803
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0879121	3.3453844463089086
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.0862745	3.283067637026962
WILLIAMS-BEUREN SYNDROME; WBS	0.08356435000000001	3.1799362858572806
#228900 FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY;;DU PAN SYNDROME	0.08333330000000001	3.1711439685730882
ZTTK SYNDROME; ZTTKS	0.08298730000000001	3.1579773735489347
#606703 DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM	0.08265175999999999	3.1452088206749327
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.08265175999999999	3.1452088206749327
MEIER-GORLIN SYNDROME 6; MGORS6	0.08245944000000001	3.137890324851104
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.08243493	3.1369576276139877
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.08187512	3.1156547618322783
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.0818005	3.112815191541231
OTOFACIOCERVICAL SYNDROME	0.0810457	3.084092226442298
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.080303	3.0558297116317807
JACOBSEN SYNDROME	0.08018439000000001	3.05131615719301
TARP SYNDROME; TARPS	0.08015988000000002	3.0503834599558948
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.07997188000000001	3.043229356301152
COHEN SYNDROME	0.07954499	3.026984594018317
ALAGILLE SYNDROME 1; ALGS1	0.07941066000000001	3.021872834742032
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.07938615	3.0209401375049167
ULNAR-MAMMARY SYNDROME; UMS	0.0787878	2.998170680473985
PELVIS-SHOULDER DYSPLASIA	0.0787878	2.998170680473985
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.0787878	2.998170680473985
KNIEST-LIKE DYSPLASIA, LETHAL	0.0781134	2.972507236299739
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.07803669	2.9695881336861474
ATKIN-FLAITZ SYNDROME	0.07768040000000001	2.9560299656481255
CLARK-BARAITSER SYNDROME	0.07768040000000001	2.9560299656481255
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.07692310000000001	2.927211866192081
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.07692310000000001	2.927211866192081
SPONDYLOOCULAR SYNDROME; SOS	0.07692310000000001	2.927211866192081
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.07692310000000001	2.927211866192081
#613707 LEOPARD SYNDROME 3; LPRD3	0.07692310000000001	2.927211866192081
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.07692310000000001	2.927211866192081
SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1	0.07692310000000001	2.927211866192081
CZECH DYSPLASIA, METATARSAL TYPE	0.07692310000000001	2.927211866192081
SJOGREN-LARSSON SYNDROME; SLS	0.07692310000000001	2.927211866192081
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.07692310000000001	2.927211866192081
MEIER-GORLIN SYNDROME 5; MGORS5	0.07692310000000001	2.927211866192081
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.07692310000000001	2.927211866192081
OROFACIODIGITAL SYNDROME III	0.07658324000000001	2.9142789211489917
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.07637921	2.906514815996454
MARFAN SYNDROME; MFS	0.07605656999999999	2.894237156405145
BENT BONE DYSPLASIA SYNDROME; BBDS	0.075	2.8540307133280645
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.07459209	2.8385082110844158
MUCOLIPIDOSIS III ALPHA/BETA	0.0742166	2.8242194111837815
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.07416484	2.8222497494541567
MUCOLIPIDOSIS III GAMMA	0.07392678	2.813190675432625
PARKINSON DISEASE, LATE-ONSET; PD	0.07280167	2.770376028820991
RITSCHER-SCHINZEL SYNDROME 1	0.07254219	2.7605018436277335
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.07254219	2.7605018436277335
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.07182134	2.7330708030983657
BARATELA-SCOTT SYNDROME	0.07163846000000001	2.7261115346069875
RENPENNING SYNDROME 1; RENS1	0.07154481000000001	2.722547801589612
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.07142903	2.7181419392430897
184705 STEINFELD SYNDROME	0.07142860000000001	2.7181255761336667
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.07024333999999999	2.6730219968899434
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.06983125999999999	2.6573408105386336
PARKINSONISM WITH SPASTICITY, X-LINKED	0.06983125999999999	2.6573408105386336
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.06983125999999999	2.6573408105386336
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.06983125999999999	2.6573408105386336
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.06912974999999999	2.6306457293958765
MARFANOID HABITUS WITH SITUS INVERSUS	0.06843888000000001	2.6043555400769844
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.0673077	2.561309907246285
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.0671485	2.5552517513854607
211120 BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	0.0671485	2.5552517513854607
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.0667311	2.539368119122219
#614251 PARKINSON DISEASE 18; PARK18	0.0666667	2.536917458083041
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.0666667	2.536917458083041
Jawad syndrome	0.0666667	2.536917458083041
WAISMAN SYNDROME; WSMN	0.0666667	2.536917458083041
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.0666667	2.536917458083041
#614203 PARKINSON DISEASE 17; PARK17	0.0666667	2.536917458083041
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.0666667	2.536917458083041
#607688 PARKINSON DISEASE 11, AUTOSOMAL DOMINANT; PARK11	0.0666667	2.536917458083041
#613702 KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT; KFS3	0.0666667	2.536917458083041
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.0666667	2.536917458083041
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.0666667	2.536917458083041
HAMAMY SYNDROME; HMMS	0.06644119	2.528335958534206
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.06609935	2.5153276670802853
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.0660173	2.512205357479904
Diamond-Blackfan anemia 1	0.06593961000000001	2.5092489621983254
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.06544892	2.490576371122019
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.06493748	2.4711141648816928
CRANIOFACIOFRONTODIGITAL SYNDROME	0.06487844000000001	2.468867471904161
EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	0.06397814	2.4346076872213707
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.06304678	2.399165953285834
#151210 PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE; PLSDT;;LETHAL SHORT-LIMBED PLATYSPONDYLIC DWARFISM, TORRANCE TYPE;;THANATOPHORIC DYSPLASIA, TORRANCE VARIANTPLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, LUTON TYPE, INCLUDED; PLSDL,INCLUDED;;THANATOPHORIC DYSPLASIA, LUTON VARIANT, INCLUDED	0.06287699999999999	2.392705188825716
THORACIC DYSOSTOSIS, ISOLATED	0.061314139999999996	2.333232516283957
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.060989	2.3208597223355376
ATELOSTEOGENESIS, TYPE I; AO1	0.060989	2.3208597223355376
RAYNAUD-CLAES SYNDROME; MRXSRC	0.06079708	2.3135564480088457
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.058833579999999996	2.2388379239339167
GRANT SYNDROME	0.0588235	2.2384543422060452
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.0588235	2.2384543422060452
CHROMOSOME 8q22.1 DUPLICATION SYNDROME	0.0588235	2.2384543422060452
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0588235	2.2384543422060452
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.0588235	2.2384543422060452
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.0588235	2.2384543422060452
TONNE-KALSCHEUER SYNDROME; TOKAS	0.058540499999999995	2.227685132981087
COSTELLO SYNDROME; CSTLO	0.057372490000000005	2.18323798080143
SMITH-MCCORT DYSPLASIA 2; SMC2	0.05709438000000001	2.1726548543789814
THORACOMELIC DYSPLASIA	0.056159499999999994	2.137079171268632
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.05612334	2.13570314792738
Myhre syndrome	0.05511916	2.097490340437916
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.05511916	2.097490340437916
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.05506988	2.0956150519905457
SECKEL SYNDROME 1; SCKL1	0.054950610000000004	2.0910763820814973
SECKEL SYNDROME 5; SCKL5	0.054950610000000004	2.0910763820814973
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.05418578	2.0619717379418345
LATERAL MENINGOCELE SYNDROME	0.05418578	2.0619717379418345
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.053072190000000005	2.019595470447768
MACS SYNDROME	0.053033550000000006	2.018125073824261
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.052756029999999995	2.00756439911009
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.052693189999999994	2.0051731019097496
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.0526316	2.002829371887965
WEILL-MARCHESANI SYNDROME 2; WMS2	0.0526316	2.002829371887965
WEILL-MARCHESANI SYNDROME 1; WMS1	0.0526316	2.002829371887965
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.0526316	2.002829371887965
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.0526316	2.002829371887965
PALLISTER-HALL SYNDROME	0.0526316	2.002829371887965
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.052463050000000004	1.9964154135315457
MENTAL RETARDATION, X-LINKED 90	0.052360079999999996	1.9924970196308602
CHROMOSOME 10Q26 DELETION SYNDROME	0.05210443	1.982768580272696
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.05189850000000001	1.9749321730087543
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0518659	1.9736916209920277
PSEUDOTRISOMY 13 SYNDROME	0.05111359	1.9450634097127761
STUVE-WIEDEMANN SYNDROME	0.051024389999999996	1.9416690158510579
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.050966330000000004	1.939459615541514
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.050609140000000004	1.925867199134932
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0501179	1.9071736785000615
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.05	1.90268714221871
SECKEL SYNDROME 4	0.05	1.90268714221871
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.04994205	1.9004819278208782
MARDEN-WALKER SYNDROME	0.0495425	1.8852775548674088
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.04949117	1.883324256247207
RIGID SPINE MUSCULAR DYSTROPHY 1	0.04903114	1.8658183929265093
PRIMROSE SYNDROME; PRIMS	0.04862973	1.8505432400113493
#607346 SPINOCEREBELLAR ATAXIA 19; SCA19;;SPINOCEREBELLAR ATAXIA 22; SCA22	0.04861906	1.8501372065751995
DYSTONIA, DOPA-RESPONSIVE; DRD	0.04861906	1.8501372065751995
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.04861906	1.8501372065751995
#609270 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7	0.04861906	1.8501372065751995
SPINOCEREBELLAR ATAXIA 15	0.04861906	1.8501372065751995
NEMALINE MYOPATHY 2; NEM2	0.04791755	1.8234421254324427
VAN MALDERGEM SYNDROME 1; VMLDS1	0.04789894	1.8227339452781088
VAN MALDERGEM SYNDROME 2; VMLDS2	0.04789894	1.8227339452781088
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0478261	1.8199621106493247
CDAGS SYNDROME	0.0478261	1.8199621106493247
LEGIUS SYNDROME	0.04705494	1.7906165863174572
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.04656809	1.7720901216136735
SPINOCEREBELLAR ATAXIA 2; SCA2	0.04656809	1.7720901216136735
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.045965860000000004	1.7491730160605061
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.045965860000000004	1.7491730160605061
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.045941350000000006	1.7482403188233904
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.045580140000000005	1.734494926370574
GILLESPIE SYNDROME; GLSP	0.0454545	1.7297138541196067
SPINOCEREBELLAR ATAXIA 20	0.0454545	1.7297138541196067
DYSTONIA, JUVENILE-ONSET	0.0454545	1.7297138541196067
#535000 LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON	0.0454545	1.7297138541196067
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.0454545	1.7297138541196067
#608627 AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8	0.0454545	1.7297138541196067
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.0454545	1.7297138541196067
#614782 TREMOR, HEREDITARY ESSENTIAL, 4; ETM4	0.0454545	1.7297138541196067
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.0454545	1.7297138541196067
REIFENSTEIN SYNDROME	0.0454545	1.7297138541196067
BARTSOCAS-PAPAS SYNDROME; BPS	0.0454545	1.7297138541196067
DYSTONIA 27; DYT27	0.0454545	1.7297138541196067
SPONDYLOPERIPHERAL DYSPLASIA	0.045329680000000004	1.7249639859377723
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.045329680000000004	1.7249639859377723
JOUBERT SYNDROME 21	0.04526784999999999	1.722611123017704
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.04524333999999999	1.7216784257805884
#615290 SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMALDOMINANT; SMALED2	0.04499456	1.7122114156357653
#300799 MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR	0.04436104	1.6881036084689973
GAPO SYNDROME; GAPOS	0.044154259999999994	1.6802348555236375
NOONAN SYNDROME 5; NS5	0.043478300000000004	1.6545120475105546
MEESTER-LOEYS SYNDROME; MRLS	0.043478300000000004	1.6545120475105546
NOONAN SYNDROME 10; NS10	0.043478300000000004	1.6545120475105546
NOONAN SYNDROME 8; NS8	0.043478300000000004	1.6545120475105546
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.043478300000000004	1.6545120475105546
#611554 LEOPARD SYNDROME 2	0.043478300000000004	1.6545120475105546
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.043478300000000004	1.6545120475105546
FIBROMATOSIS, GINGIVAL, 5; GINGF5	0.043478300000000004	1.6545120475105546
#604308 MASS SYNDROME;;MASS PHENOTYPE;;OVERLAP CONNECTIVE TISSUE DISEASE; OCTD	0.043478300000000004	1.6545120475105546
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.043438550000000006	1.6529994112324908
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.04334743	1.6495319541845113
PYLE DISEASE; PYL	0.0430147	1.6368703323279026
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.042888550000000004	1.632069852668085
INFANTILE SIALIC ACID STORAGE DISEASE	0.04191884	1.5951687576944669
SIFRIM-HITZ-WEISS SYNDROME	0.04153909	1.5807178488493157
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.041332690000000005	1.5728635563262368
RAINE SYNDROME	0.04095099000000001	1.5583384426825393
HURLER SYNDROME	0.0404255	1.538341581355249
WITTEVEEN-KOLK SYNDROME	0.04036298	1.5359624613526186
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.03950666	1.503376280280124
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.03929094	1.495167326873736
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03880294	1.4765971003656813
THUMBS, CONGENITAL CLASPED	0.0384757	1.4641443935572882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.03839682	1.4611427143217237
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.03839307	1.4610000127860576
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.0383422	1.4590642188875642
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	0.0383422	1.4590642188875642
WHITE-SUTTON SYNDROME; WHSUS	0.0383223	1.4583069494049612
#300867 KABUKI SYNDROME 2; KABUK2	0.0383223	1.4583069494049612
COLE-CARPENTER SYNDROME 2; CLCRP2	0.03792069	1.443024185741232
DESBUQUOIS DYSPLASIA 1	0.03774359000000001	1.4362848678834936
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.03740570000000001	1.423426888713808
SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE	0.03740570000000001	1.423426888713808
VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR	0.03740570000000001	1.423426888713808
MENTAL RETARDATION, X-LINKED 105; MRX105	0.03728323	1.4187664468276573
SMITH-KINGSMORE SYNDROME; SKS	0.03693445	1.4054940623983965
KETOADIPICACIDURIA	0.03682789	1.4014390555609
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.03682789	1.4014390555609
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.03678634	1.3998579225457162
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.036420469999999996	1.3859351996512448
GAUCHER DISEASE, PERINATAL LETHAL	0.03582086	1.3631177949043298
SWEENEY-COX SYNDROME; SWCOS	0.035796350000000005	1.3621850976672143
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.035714300000000004	1.3590627880668333
#113500 BRACHYOLMIA TYPE 3;;BRACHYOLMIA, AUTOSOMAL DOMINANT;;BRACHYRACHIA	0.035714300000000004	1.3590627880668333
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.035714300000000004	1.3590627880668333
LANDAU-KLEFFNER SYNDROME	0.03530688	1.3435589321571784
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.03528738	1.3428168841717132
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.035256380000000004	1.3416372181435376
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.03474566	1.3222024105980585
2q33.1 deletion syndrome	0.03472115	1.321269713360943
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.03457051	1.3155372975388664
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0341006	1.2976554632388666
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.03371305	1.2829077351995295
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.033371689999999996	1.2699177095421736
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.03335178	1.2691600595221422
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.03335178	1.2691600595221422
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.0333333	1.2684568263543785
PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA	0.0333333	1.2684568263543785
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.0333333	1.2684568263543785
HYDROPS FETALIS, NONIMMUNE, WITH GRACILE BONES AND DYSMORPHIC FEATURES	0.0333333	1.2684568263543785
CRANIOECTODERMAL DYSPLASIA 1	0.03309949	1.2595594807399353
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.03295117	1.2539153496012578
#278250 WRINKLY SKIN SYNDROME; WSS	0.03288867	1.2515369906734841
BREATH-HOLDING SPELLS	0.0322581	1.227541442048107
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.0322581	1.227541442048107
HISTIDINEMIA	0.0322581	1.227541442048107
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.0322581	1.227541442048107
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0322581	1.227541442048107
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.0322581	1.227541442048107
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.0322581	1.227541442048107
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.0322581	1.227541442048107
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.0322581	1.227541442048107
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.03183761	1.2115402237194763
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.031837580000000004	1.211539082107191
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.031416589999999994	1.1955188369071377
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.03125	1.1891794638866935
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.03125	1.1891794638866935
SERTOLI CELL-ONLY SYNDROME	0.03125	1.1891794638866935
HERNIA, HIATUS	0.03125	1.1891794638866935
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.03125	1.1891794638866935
SCALP-EAR-NIPPLE SYNDROME; SENS	0.03125	1.1891794638866935
#615348 NEMALINE MYOPATHY 8; NEM8	0.03125	1.1891794638866935
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.03125	1.1891794638866935
FIBROSCLEROSIS, MULTIFOCAL	0.03125	1.1891794638866935
#253310 LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1;;LCCS;;MULTIPLE CONTRACTURE SYNDROME, FINNISH TYPE	0.03125	1.1891794638866935
PYCNODYSOSTOSIS	0.03125	1.1891794638866935
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	0.03125	1.1891794638866935
OCULOCEREBROCUTANEOUS SYNDROME	0.03125	1.1891794638866935
104600 AMENORRHEA-GALACTORRHEA SYNDROME	0.03125	1.1891794638866935
NIPPLES, SUPERNUMERARY	0.03125	1.1891794638866935
BREAST, UNILATERAL GIANT	0.03125	1.1891794638866935
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.03125	1.1891794638866935
FASCIAL DYSTROPHY, CONGENITAL	0.03125	1.1891794638866935
GALACTORRHEA	0.03125	1.1891794638866935
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.03125	1.1891794638866935
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.03125	1.1891794638866935
ACHONDROPLASIA, SO-CALLED, AND SEVERE COMBINED IMMUNODEFICIENCY	0.03125	1.1891794638866935
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.03109109	1.183132343611294
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.03103765	1.1810987515936906
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.03076004	1.170534652042664
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.03073553	1.1696019548055483
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.030632600000000003	1.165685083054577
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.03057988	1.1636788897318215
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.030302999999999997	1.153142569413071
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.030302999999999997	1.153142569413071
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.030302999999999997	1.153142569413071
GRACILE BONE DYSPLASIA; GCLEB	0.030302999999999997	1.153142569413071
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.030302999999999997	1.153142569413071
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.02983989	1.1355195005644132
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.029343920000000003	1.1166459857258888
COFFIN-SIRIS SYNDROME 6; CSS6	0.02922971	1.1122998677556328
BRUCK SYNDROME 2	0.02922318	1.112051376814859
#259450 BRUCK SYNDROME 1; BRKS1	0.02922318	1.112051376814859
LAMB-SHAFFER SYNDROME	0.02908581	1.1068239341603274
COWDEN SYNDROME 6; CWS6	0.028894290000000003	1.099535881330773
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.028894290000000003	1.099535881330773
COWDEN SYNDROME 5; CWS5	0.028894290000000003	1.099535881330773
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.02860353	1.0884713750613424
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.02860353	1.0884713750613424
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.02852516	1.085489103234629
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.02824658	1.0748880915530432
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.028222070000000002	1.0739553943159277
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.028104050000000005	1.0694642915854349
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.02792642	1.0627048052439885
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.027908340000000004	1.0620167935733622
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.027607190000000004	1.050556908915779
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.02759052	1.049922553022563
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.02748994	1.046095107567276
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.02722549	1.0360317952720812
KOOLEN-DE VRIES SYNDROME; KDVS	0.02708812	1.0308043526175494
DESANTO-SHINAWI SYNDROME	0.02656263	1.0108074912902594
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.02653472	1.0097454113274729
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.02630173	1.000879269782162
NEMALINE MYOPATHY 4	0.02579884	0.9817424230431547
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.02579884	0.9817424230431547
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.02575902	0.9802271230030918
CHROMOSOME 17P13.1 DELETION SYNDROME	0.025672	0.9769156863007743
HYPOCHONDROPLASIA	0.025641000000000004	0.9757360202725989
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.025641000000000004	0.9757360202725989
TIBIA VARA	0.025641000000000004	0.9757360202725989
EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	0.025641000000000004	0.9757360202725989
#100800 ACHONDROPLASIA; ACH	0.025641000000000004	0.9757360202725989
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.025641000000000004	0.9757360202725989
#156500 METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE; MCDS;;SPONDYLOMETAPHYSEAL DYSPLASIA, JAPANESE TYPE	0.025641000000000004	0.9757360202725989
BLOUNT DISEASE, ADOLESCENT	0.025641000000000004	0.9757360202725989
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.025641000000000004	0.9757360202725989
METAPHYSEAL ACROSCYPHODYSPLASIA	0.025641000000000004	0.9757360202725989
SPINOCEREBELLAR ATAXIA 5; SCA5	0.02555475	0.9724538849522714
#600972 ACHONDROGENESIS, TYPE IB; ACG1B;;ACHONDROGENESIS, FRACCARO TYPE	0.0254818	0.9696778644117743
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.0254818	0.9696778644117743
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.0254818	0.9696778644117743
METATROPIC DYSPLASIA	0.0254818	0.9696778644117743
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.025438969999999998	0.9680480226057497
VERVERI-BRADY SYNDROME; VERBRAS	0.025438969999999998	0.9680480226057497
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.0249935	0.9510962217808663
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.024685250000000002	0.9393661555490882
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.024685250000000002	0.9393661555490882
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.024685250000000002	0.9393661555490882
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.024685250000000002	0.9393661555490882
SOTOS SYNDROME 2	0.02462507	0.9370760813047135
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.02448451	0.9317272472105084
SPINOCEREBELLAR ATAXIA 34; SCA34	0.02444116	0.9300776174582047
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.02444116	0.9300776174582047
SPINOCEREBELLAR ATAXIA 40; SCA40	0.02444116	0.9300776174582047
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.02444116	0.9300776174582047
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.02444116	0.9300776174582047
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.02444116	0.9300776174582047
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.02444116	0.9300776174582047
#613908 SPINOCEREBELLAR ATAXIA 35; SCA35	0.02444116	0.9300776174582047
#613728 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10	0.02444116	0.9300776174582047
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.02432538	0.9256717551116832
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.02377017	0.9045439365470581
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.02376416	0.9043152335525634
MOWAT-WILSON SYNDROME; MOWS	0.023396300000000002	0.8903167837098319
BETHLEM MYOPATHY 2; BTHLM2	0.023335790000000002	0.888014151730319
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.02318444	0.8822547177508229
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.022772360000000002	0.8665735313995131
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.022656580000000003	0.8621676690529916
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.02241467	0.8529620881215089
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.02239019	0.8520305324966787
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.02239019	0.8520305324966787
PEROXISOME BIOGENESIS DISORDER 6B	0.02239019	0.8520305324966787
#604286 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E; LGMD2E	0.0222222	0.8456378842362522
#300695 SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM;;SCAPULOPERONEAL MYOPATHY, FHL1-RELATED	0.0222222	0.8456378842362522
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.0222222	0.8456378842362522
#181350 EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2;;EMD2;;EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT;;SCAPULOILIOPERONEAL ATROPHY WITH CARDIOPATHY;;MUSCULAR DYSTROPHY WITH EARLY CONTRACTURES AND CARDIOMYOPATHY, AUTOSOMALDOMINANT;;HAUPTMANN-THANNHAUSER MUSCULAR DYSTROPHYEMERY-DREIFUSS MUSCULAR DYSTROPHY, ATYPICAL, AUTOSOMAL RECESSIVE,INCLUDED;;EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE, INCLUDED;EDMD3, INCLUDED	0.0222222	0.8456378842362522
#158901 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2; FSHD2;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC;;FSHD2, DIGENIC;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 2;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1B; FSHD1B	0.0222222	0.8456378842362522
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.0222222	0.8456378842362522
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.0222222	0.8456378842362522
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.0222222	0.8456378842362522
OTOFACIOCERVICAL SYNDROME 2	0.0222222	0.8456378842362522
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	0.0222222	0.8456378842362522
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0222222	0.8456378842362522
MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL	0.0222222	0.8456378842362522
#300696 MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY; XMPMAEMERY-DREIFUSS MUSCULAR DYSTROPHY 6, X-LINKED, INCLUDED; EDMD6, INCLUDED	0.0222222	0.8456378842362522
#615325 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2R; LGMD2R	0.0222222	0.8456378842362522
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.0222222	0.8456378842362522
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.0222222	0.8456378842362522
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.0222222	0.8456378842362522
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7	0.0222222	0.8456378842362522
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.0222222	0.8456378842362522
%601846 VACUOLAR NEUROMYOPATHY;;MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV	0.0222222	0.8456378842362522
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.0222222	0.8456378842362522
MYOPATHY, SCAPULOHUMEROPERONEAL	0.0222222	0.8456378842362522
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Z	0.0222222	0.8456378842362522
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.022120030000000002	0.8417499333298426
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.022070850000000003	0.8398784502567563
ROBERTS SYNDROME; RBS	0.022070850000000003	0.8398784502567563
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.02193348	0.8346510076022245
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.02186222	0.8319392978871345
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.02139544	0.8141765718022375
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.02131995	0.8113038947549157
DEMENTIA, FAMILIAL DANISH	0.0212766	0.809654265002612
EPISODIC ATAXIA, TYPE 8	0.0212766	0.809654265002612
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.0212766	0.809654265002612
MYOCLONUS AND ATAXIA	0.0212766	0.809654265002612
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0212766	0.809654265002612
Boucher-Neuhauser syndrome	0.0212766	0.809654265002612
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.0212766	0.809654265002612
#117360 SPINOCEREBELLAR ATAXIA 29; SCA29;;CEREBELLAR ATAXIA, CONGENITAL NONPROGRESSIVE, AUTOSOMAL DOMINANT;CNPCA;;CEREBELLAR VERMIS APLASIA;;APLASIA OF CEREBELLAR VERMIS; ACV	0.0212766	0.809654265002612
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.0212766	0.809654265002612
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0212766	0.809654265002612
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.021026290000000003	0.8001290326312367
CRI-DU-CHAT SYNDROME	0.02081989	0.7922747401081578
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.020721390000000003	0.7885264464379871
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.020721390000000003	0.7885264464379871
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.020721390000000003	0.7885264464379871
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.020721390000000003	0.7885264464379871
OROFACIODIGITAL SYNDROME XIV; OFD14	0.02063152	0.7851065565685631
DYSTONIA 11, MYOCLONIC	0.02006906	0.7637028483683164
MENTAL RETARDATION, BUENOS AIRES TYPE	0.01972063	0.750443782749051
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.01961528	0.7464348209403961
LETTERER-SIWE DISEASE	0.0196078	0.7461501789439204
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	0.7461501789439204
TOE, MISSHAPEN	0.0196078	0.7461501789439204
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	0.7461501789439204
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.0196078	0.7461501789439204
VAN DEN BOSCH SYNDROME	0.0196078	0.7461501789439204
HHHH SYNDROME	0.0196078	0.7461501789439204
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0196078	0.7461501789439204
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0196078	0.7461501789439204
#148210 KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT;;KID SYNDROME, AUTOSOMAL DOMINANT	0.0196078	0.7461501789439204
BEEMER LETHAL MALFORMATION SYNDROME	0.0196078	0.7461501789439204
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.0196078	0.7461501789439204
THROMBOCYTOPENIA 3	0.0196078	0.7461501789439204
MONOPHALANGY OF GREAT TOE	0.0196078	0.7461501789439204
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0196078	0.7461501789439204
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	0.7461501789439204
VESICOURETERAL REFLUX 1	0.0196078	0.7461501789439204
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	0.7461501789439204
SPINAL ARACHNOIDITIS	0.0196078	0.7461501789439204
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0196078	0.7461501789439204
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0196078	0.7461501789439204
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	0.7461501789439204
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0196078	0.7461501789439204
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	0.7461501789439204
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.0196078	0.7461501789439204
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	0.7461501789439204
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.0196078	0.7461501789439204
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	0.7461501789439204
KNUCKLE PADS	0.0196078	0.7461501789439204
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.0196078	0.7461501789439204
DOUBLE NAIL FOR FIFTH TOE	0.0196078	0.7461501789439204
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.0196078	0.7461501789439204
MICROPHTHALMIA, SYNDROMIC 4	0.0196078	0.7461501789439204
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.0196078	0.7461501789439204
THROMBOCYTHEMIA, ESSENTIAL	0.0196078	0.7461501789439204
RAYNAUD DISEASE	0.0196078	0.7461501789439204
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0196078	0.7461501789439204
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0196078	0.7461501789439204
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.0196078	0.7461501789439204
PACHYDERMODACTYLY, FAMILIAL	0.0196078	0.7461501789439204
THALIDOMIDE SUSCEPTIBILITY	0.0196078	0.7461501789439204
NEPHROSIALIDOSIS	0.0196078	0.7461501789439204
MEGAEPIPHYSEAL DWARFISM	0.0196078	0.7461501789439204
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	0.7461501789439204
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.0196078	0.7461501789439204
TRACHEOBRONCHOMEGALY	0.0196078	0.7461501789439204
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0196078	0.7461501789439204
#600175 SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE;;SPINAL MUSCULAR ATROPHY, CONGENITAL BENIGN, WITH CONTRACTURES	0.0196078	0.7461501789439204
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.0196078	0.7461501789439204
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	0.7461501789439204
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.0196078	0.7461501789439204
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	0.7461501789439204
PUBIC BONE DYSPLASIA	0.0196078	0.7461501789439204
BAND HETEROTOPIA; BH	0.0196078	0.7461501789439204
CARPAL DISPLACEMENT	0.0196078	0.7461501789439204
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	0.7461501789439204
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	0.7461501789439204
#215300 CHONDROSARCOMA	0.0196078	0.7461501789439204
CIRCUMVALLATE PLACENTA SYNDROME	0.0196078	0.7461501789439204
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	0.7461501789439204
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.01947043	0.7409227362893887
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.01947043	0.7409227362893887
MENTAL RETARDATION, X-LINKED 104; MRX104	0.019275269999999997	0.7334961678358805
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.01917063	0.7295142241846453
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.018959220000000002	0.7214692824099163
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.018959220000000002	0.7214692824099163
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.018955470000000002	0.7213265808742497
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.01889677	0.7190928261692849
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0188847	0.7186335174931534
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.7179942146133678
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	0.7179942146133678
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.7179942146133678
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	0.7179942146133678
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.7179942146133678
RHEUMATOID ARTHRITIS	0.0188679	0.7179942146133678
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.7179942146133678
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	0.7179942146133678
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	0.7179942146133678
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	0.7179942146133678
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.7179942146133678
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	0.7179942146133678
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	0.7179942146133678
MOTION SICKNESS	0.0188679	0.7179942146133678
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	0.7179942146133678
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.7179942146133678
CARDIAC ARRHYTHMIA	0.0188679	0.7179942146133678
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.7179942146133678
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.7179942146133678
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	0.7179942146133678
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.7179942146133678
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	0.7179942146133678
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	0.7179942146133678
ERYTHERMALGIA, PRIMARY	0.0188679	0.7179942146133678
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	0.7179942146133678
TRANSSEXUALITY	0.0188679	0.7179942146133678
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.7179942146133678
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.7179942146133678
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	0.7179942146133678
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.7179942146133678
269800 SENILE PLAQUE FORMATION	0.0188679	0.7179942146133678
PALMOMENTAL REFLEX	0.0188679	0.7179942146133678
ENDOCARDIAL FIBROELASTOSIS	0.0188679	0.7179942146133678
ALCOHOL DEPENDENCE	0.0188679	0.7179942146133678
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	0.7179942146133678
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	0.7179942146133678
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	0.7179942146133678
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.7179942146133678
JUMPING FRENCHMAN OF MAINE	0.0188679	0.7179942146133678
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	0.7179942146133678
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.7179942146133678
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.7179942146133678
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.7179942146133678
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	0.7179942146133678
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	0.7179942146133678
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	0.7179942146133678
DIASTEMATOMYELIA	0.0188679	0.7179942146133678
MYOPATHY, CONGENITAL	0.0188679	0.7179942146133678
ARTERIAL TORTUOSITY SYNDROME	0.01834666	0.6981590816931662
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.01833233	0.6976137715582064
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.0180812	0.6880573351176986
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.01789967	0.6811494391791595
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.01784563	0.6790930149158495
Xq28 (MECP2) duplication	0.01784563	0.6790930149158495
Glycosylphosphatidylinositol biosynthesis defect 18	0.017821169999999997	0.6781622203658759
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.017821169999999997	0.6781622203658759
SAUL-WILSON SYNDROME; SWILS	0.0178188	0.6780720329953348
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.01774494	0.6752613835488495
WIEACKER-WOLFF SYNDROME	0.01761442	0.6702946090328016
MCDONOUGH SYNDROME	0.01725758	0.6567155114362152
#614976 CARPENTER SYNDROME 2; CRPT2	0.01723307	0.6557828141990996
CATEL-MANZKE SYNDROME; CATMANS	0.01723307	0.6557828141990996
LOEYS-DIETZ SYNDROME 5	0.01723307	0.6557828141990996
MARFANOID HYPERMOBILITY SYNDROME	0.01723307	0.6557828141990996
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.01723307	0.6557828141990996
MARTSOLF SYNDROME	0.01723307	0.6557828141990996
XQ25 DUPLICATION SYNDROME	0.016982870000000004	0.6462617677394372
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.01698287	0.6462617677394372
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.01698287	0.6462617677394372
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.01698287	0.6462617677394372
TENORIO SYNDROME; TNORS	0.01698287	0.6462617677394372
LUSCAN-LUMISH SYNDROME; LLS	0.01698287	0.6462617677394372
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.01695585	0.6452335556077822
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.01692097	0.6439062410573704
NEUROFIBROMATOSIS, TYPE I	0.01691934	0.6438442134565342
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.01691934	0.6438442134565342
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.01639714	0.6239725489432019
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.01639548	0.6239093797300802
TYSHCHENKO SYNDROME	0.01614364	0.614325925132153
CRANIOECTODERMAL DYSPLASIA 4	0.01614364	0.614325925132153
STIFF-PERSON SYNDROME; SPS	0.015985060000000002	0.6082913625918922
PHENYLKETONURIA	0.015985060000000002	0.6082913625918922
MENTAL RETARDATION, X-LINKED 63	0.015985060000000002	0.6082913625918922
PRADER-WILLI SYNDROME; PWS	0.01592707	0.606084626044347
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.01588361	0.6044308103803303
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.015869280000000003	0.6038855002453706
SPINOCEREBELLAR ATAXIA 43; SCA43	0.01575035	0.5993597686088891
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.01571848	0.5981469958244389
PITT-HOPKINS SYNDROME	0.01571848	0.5981469958244389
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.01569397	0.5972142985873233
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.01560639	0.5938815517890129
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.01528189	0.5815331122360134
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0152675	0.580985518876483
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.01520737	0.5786973473192508
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.014811359999999999	0.5636276846154501
%605967 ACROPECTORAL SYNDROME; ACRPS;;ACRP SYNDROME;;SYNDACTYLY, PREAXIAL POLYDACTYLY, AND STERNAL DEFORMITY	0.01477002	0.5620545428862638
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.01477002	0.5620545428862638
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.01477002	0.5620545428862638
#100100 PRUNE BELLY SYNDROME; PBS;;ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY ANDCRYPTORCHIDISM;;EAGLE-BARRETT SYNDROME; EGBRS	0.01477002	0.5620545428862638
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.01477002	0.5620545428862638
TEEBI-SHALTOUT SYNDROME; TBSH	0.01477002	0.5620545428862638
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.01477002	0.5620545428862638
CHROMOSOME 16Q22 DELETION SYNDROME	0.014565640000000001	0.5542771189237305
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.014565640000000001	0.5542771189237305
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.0144928	0.5515052842949463
THORACOPELVIC DYSOSTOSIS	0.0144928	0.5515052842949463
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.0144928	0.5515052842949463
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.01432466	0.5451069279730932
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.01426762	0.5429363424812501
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.01425389	0.5424138645919969
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.01403778	0.5341900702258991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.013934090000000001	0.5302442776303661
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.013934090000000001	0.5302442776303661
HAREL-YOON SYNDROME; HAYOS	0.01377775	0.5242949554740766
COFFIN-SIRIS SYNDROME 7; CSS7	0.01374213	0.5229394811539599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.01374213	0.5229394811539599
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.0134619	0.512275680796681
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.013461899999999999	0.5122756807966808
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.013461899999999999	0.5122756807966808
#615731 NEMALINE MYOPATHY 9; NEM9	0.01345205	0.5119008514296639
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.01345205	0.5119008514296639
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.01323092	0.5034860272744874
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.013192019999999999	0.5020057366778412
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.0131403	0.5000375970979303
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.01290068	0.49091915923756124
CODAS SYNDROME	0.01287829	0.49006713593527573
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.01287829	0.49006713593527573
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.01287829	0.49006713593527573
SPINOCEREBELLAR ATAXIA 48; SCA48	0.012820500000000002	0.48786801013629943
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.012820500000000002	0.48786801013629943
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.012820500000000002	0.48786801013629943
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.012820500000000002	0.48786801013629943
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.012820500000000002	0.48786801013629943
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.012820500000000002	0.48786801013629943
ADIPOSIS DOLOROSA	0.012820500000000002	0.48786801013629943
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.012820500000000002	0.48786801013629943
#118700 CHOREA, BENIGN HEREDITARY; BHC;;BCH;;HEREDITARY PROGRESSIVE CHOREA WITHOUT DEMENTIA	0.012820500000000002	0.48786801013629943
HUNTINGTON DISEASE-LIKE 1	0.012820500000000002	0.48786801013629943
PANIC DISORDER 1	0.012820500000000002	0.48786801013629943
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.012820500000000002	0.48786801013629943
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012820500000000002	0.48786801013629943
KOSAKI OVERGROWTH SYNDROME; KOGS	0.012820500000000002	0.48786801013629943
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.012820500000000002	0.48786801013629943
DYSTONIA 12; DYT12	0.012820500000000002	0.48786801013629943
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.012820500000000002	0.48786801013629943
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.012820500000000002	0.48786801013629943
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.012820500000000002	0.48786801013629943
GENIOSPASM 1; GSM1	0.012820500000000002	0.48786801013629943
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.012820500000000002	0.48786801013629943
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.012820500000000002	0.48786801013629943
OBSESSIVE-COMPULSIVE DISORDER 1	0.012820500000000002	0.48786801013629943
DYSTONIA 26, MYOCLONIC; DYT26	0.012820500000000002	0.48786801013629943
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.012820500000000002	0.48786801013629943
MCLEOD SYNDROME; MCLDS	0.012820500000000002	0.48786801013629943
CREUTZFELDT-JAKOB DISEASE; CJD	0.012820500000000002	0.48786801013629943
ALAZAMI SYNDROME; ALAZS	0.012820500000000002	0.48786801013629943
HYPERTELORISM, TEEBI TYPE; TBHS	0.012820500000000002	0.48786801013629943
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0127849	0.48651329689103967
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0127849	0.48651329689103967
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.01271981	0.4840363787692993
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.01266416	0.48191868798000986
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.01234831	0.46989941330261426
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.01227369	0.4670598430115671
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.01227369	0.4670598430115671
FRAGILE X MENTAL RETARDATION SYNDROME	0.01224684	0.4660381000161956
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.01224684	0.4660381000161956
MENTAL RETARDATION, X-LINKED 103	0.012117329999999999	0.4611097597804207
COFFIN-SIRIS SYNDROME 5	0.012117329999999999	0.4611097597804207
SCHAAF-YANG SYNDROME; SHFYNG	0.012117329999999999	0.4611097597804207
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.012117329999999999	0.4611097597804207
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.01210259	0.4605488476108947
SHPRINTZEN OMPHALOCELE SYNDROME	0.01210259	0.4605488476108947
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.01210259	0.4605488476108947
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.01207843	0.45962946918377456
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.01207843	0.45962946918377456
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.01207843	0.45962946918377456
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.01207843	0.45962946918377456
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.01204281	0.45827399486365794
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.01192035	0.45361393351493595
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.01179084	0.448685593279161
MUCOLIPIDOSIS IV; ML4	0.01179084	0.448685593279161
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.01178006	0.4482753739312987
CAMURATI-ENGELMANN DISEASE	0.011764700000000001	0.4476908684412091
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.011764700000000001	0.4476908684412091
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.011764700000000001	0.4476908684412091
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.011764700000000001	0.4476908684412091
137370 GENU VALGUM, ST. HELENA FAMILIAL;;GENU VALGUM, HEREDITARY PUBERTAL	0.011764700000000001	0.4476908684412091
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.011764700000000001	0.4476908684412091
TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM	0.011764700000000001	0.4476908684412091
NIEVERGELT SYNDROME	0.011764700000000001	0.4476908684412091
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	0.011764700000000001	0.4476908684412091
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.011764700000000001	0.4476908684412091
SCHEIE SYNDROME	0.011764700000000001	0.4476908684412091
#259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2;;OSTEOPETROSIS, OSTEOCLAST-POOR;;OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM	0.011764700000000001	0.4476908684412091
#613618 CHROMOSOME 17q23.1-q23.2 DUPLICATION SYNDROME	0.011764700000000001	0.4476908684412091
EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5	0.011764700000000001	0.4476908684412091
SATOYOSHI SYNDROME	0.011764700000000001	0.4476908684412091
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.011764700000000001	0.4476908684412091
LOWE OCULOCEREBRORENAL SYNDROME	0.011764700000000001	0.4476908684412091
POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8	0.011764700000000001	0.4476908684412091
#184095 SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE;;SED, MAROTEAUX TYPE;;PSEUDO-MORQUIO SYNDROME, TYPE 2	0.011764700000000001	0.4476908684412091
#614134 STICKLER SYNDROME, TYPE IV; STL4	0.011764700000000001	0.4476908684412091
#168400 PARASTREMMATIC DWARFISM	0.011764700000000001	0.4476908684412091
EPIPHYSEAL DYSPLASIA, MULTIPLE, 1	0.011764700000000001	0.4476908684412091
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.011675060000000001	0.44427973093263945
CHROMOSOME 16p13.2 DELETION SYNDROME	0.011675060000000001	0.44427973093263945
GABRIELE-DE VRIES SYNDROME; GADEVS	0.01167131	0.44413702939697297
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.011650549999999999	0.44334703369552375
NEURAMINIDASE DEFICIENCY	0.01137035	0.4326843749505301
PETTIGREW SYNDROME	0.01137035	0.4326843749505301
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.01136798	0.4325941875799889
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.01129336	0.4297546172889417
KLEEFSTRA SYNDROME	0.01125457	0.42827851260400845
COFFIN-SIRIS SYNDROME 2; CSS2	0.01125457	0.42827851260400845
ASPARTYLGLUCOSAMINURIA; AGU	0.01125457	0.42827851260400845
SHUKLA-VERNON SYNDROME; SHUVER	0.01125457	0.42827851260400845
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.01123847	0.42766584734421403
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.01121884	0.426918852372179
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.01121884	0.426918852372179
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.01121884	0.426918852372179
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.011163949999999999	0.42483008242745124
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.0111601	0.4246835755175004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.0111601	0.4246835755175004
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.0111601	0.4246835755175004
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.01108933	0.4219905121364041
HADZISELIMOVIC SYNDROME	0.01108933	0.4219905121364041
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.01108933	0.4219905121364041
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.01108933	0.4219905121364041
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.010989	0.418172580116828
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.010989	0.418172580116828
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.010989	0.418172580116828
RUVALCABA SYNDROME	0.010989	0.418172580116828
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.010989	0.418172580116828
CRANIOECTODERMAL DYSPLASIA 3	0.010989	0.418172580116828
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.010989	0.418172580116828
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.010989	0.418172580116828
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.010989	0.418172580116828
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.010989	0.418172580116828
FACIOCARDIOMELIC SYNDROME	0.010989	0.418172580116828
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.010728969999999999	0.4082774653650053
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.010728969999999999	0.4082774653650053
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.01069335	0.4069219910448888
Helsmoortel-van der Aa syndrome	0.010693349999999999	0.4069219910448887
PALLISTER-KILLIAN SYNDROME	0.010693349999999999	0.4069219910448887
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.010693349999999999	0.4069219910448887
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.010693349999999999	0.4069219910448887
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.010668839999999999	0.40598929380777316
ZIMMERMANN-LABAND SYNDROME 1	0.010668839999999999	0.40598929380777316
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.01066647	0.40589910643723204
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.010652739999999999	0.4053766285479787
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.01041312	0.3962581906876098
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.01041312	0.3962581906876098
JABERI-ELAHI SYNDROME; JABELS	0.01041312	0.3962581906876098
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.01041312	0.3962581906876098
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.01041312	0.3962581906876098
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.01041312	0.3962581906876098
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.01041312	0.3962581906876098
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.01029734	0.3918523283410882
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.01029734	0.3918523283410882
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.01029734	0.3918523283410882
SANDHOFF DISEASE	0.01025676	0.39030810745646344
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.01025676	0.39030810745646344
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.01014098	0.38590224510994187
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.01014098	0.38590224510994187
FRONTOOCULAR SYNDROME	0.01010525	0.3845425848781123
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.01010525	0.3845425848781123
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.01010525	0.3845425848781123
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.00997574	0.3796142446423374
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.00997574	0.3796142446423374
MEHMO SYNDROME; MEHMO	0.00981449	0.3734780786086821
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.009736120000000001	0.37049580678196853
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.009736120000000001	0.37049580678196853
CHROMOSOME 18Q DELETION SYNDROME	0.009736120000000001	0.37049580678196853
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.009736120000000001	0.37049580678196853
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00961538	0.3659011978709387
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00961538	0.3659011978709387
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00961538	0.3659011978709387
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00961538	0.3659011978709387
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.00961538	0.3659011978709387
HUNTER-MACDONALD SYNDROME	0.00961538	0.3659011978709387
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.00961538	0.3659011978709387
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.00957976	0.3645457235508221
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00957976	0.3645457235508221
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00955525	0.3636130263137065
OGDEN SYNDROME; OGDNS	0.00955525	0.3636130263137065
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00955525	0.3636130263137065
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.00955525	0.3636130263137065
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.00931701	0.35454710261846284
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00931701	0.35454710261846284
CHITAYAT SYNDROME	0.00931701	0.35454710261846284
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00931701	0.35454710261846284
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.00930328	0.35402462472920954
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.00930328	0.35402462472920954
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.00930328	0.35402462472920954
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.00930328	0.35402462472920954
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.00930328	0.35402462472920954
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.00930328	0.35402462472920954
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00930328	0.35402462472920954
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.00930328	0.35402462472920954
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.00930328	0.35402462472920954
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.00930328	0.35402462472920954
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.00930328	0.35402462472920954
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.00930328	0.35402462472920954
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.00930328	0.35402462472920954
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.00930328	0.35402462472920954
JOUBERT SYNDROME 24	0.00930328	0.35402462472920954
SPINOCEREBELLAR ATAXIA 42	0.00929953	0.35388192319354317
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00929953	0.35388192319354317
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00929953	0.35388192319354317
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.00929953	0.35388192319354317
EPISODIC ATAXIA, TYPE 1; EA1	0.00929953	0.35388192319354317
KUFOR-RAKEB SYNDROME	0.00929953	0.35388192319354317
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00929953	0.35388192319354317
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00929953	0.35388192319354317
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.00929953	0.35388192319354317
#137440 GERSTMANN-STRAUSSLER DISEASE; GSD;;ENCEPHALOPATHY, SUBACUTE SPONGIFORM, GERSTMANN-STRAUSSLER TYPE;;GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; GSS;;CEREBELLAR ATAXIA, PROGRESSIVE DEMENTIA, AND AMYLOID DEPOSITS IN CNS;;AMYLOIDOSIS, CEREBRAL, WITH SPONGIFORM ENCEPHALOPATHY;;PRION DEMENTIACEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED, INCLUDED	0.00929953	0.35388192319354317
BEHR SYNDROME	0.00929953	0.35388192319354317
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00929953	0.35388192319354317
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00929953	0.35388192319354317
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.00929953	0.35388192319354317
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00929953	0.35388192319354317
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00929953	0.35388192319354317
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00929953	0.35388192319354317
#600116 PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2;;PARKINSON DISEASE, JUVENILE, AUTOSOMAL RECESSIVE; PDJ;;PARKINSONISM, EARLY-ONSET, WITH DIURNAL FLUCTUATION; EPDF	0.00929953	0.35388192319354317
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.00929953	0.35388192319354317
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00929953	0.35388192319354317
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00929953	0.35388192319354317
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00929953	0.35388192319354317
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.009228759999999999	0.35118885981244674
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.009187500000000001	0.34961876238268796
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009183750000000001	0.34947606084702154
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.009183750000000001	0.34947606084702154
#605407 SEGAWA SYNDROME, AUTOSOMAL RECESSIVE;;PARKINSONISM, INFANTILE, AUTOSOMAL RECESSIVE;;DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL RECESSIVE;;DOPA-RESPONSIVE DYSTONIA, AUTOSOMAL RECESSIVE;;TYROSINE HYDROXYLASE DEFICIENCY	0.009183750000000001	0.34947606084702154
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.009183750000000001	0.34947606084702154
PHELAN-MCDERMID SYNDROME; PHMDS	0.00911298	0.3467829974659251
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.00911298	0.3467829974659251
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.00911298	0.3467829974659251
WIEDEMANN-STEINER SYNDROME; WDSTS	0.00911298	0.3467829974659251
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00911298	0.3467829974659251
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.00911298	0.3467829974659251
DUBOWITZ SYNDROME	0.00911298	0.3467829974659251
EMANUEL SYNDROME	0.00911298	0.3467829974659251
RECOMBINANT CHROMOSOME 8 SYNDROME	0.008755790000000001	0.3331905810593432
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.008755790000000001	0.3331905810593432
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.008731280000000001	0.33225788382222754
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.008731280000000001	0.33225788382222754
AU-KLINE SYNDROME; AUKS	0.008731280000000001	0.33225788382222754
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.008731280000000001	0.33225788382222754
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.008731280000000001	0.33225788382222754
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.0087009	0.3311018111146154
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.008676389999999999	0.3301691138774998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.00862628	0.3282622408235682
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.00862628	0.3282622408235682
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.00862628	0.3282622408235682
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00862628	0.3282622408235682
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00862628	0.3282622408235682
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00862628	0.3282622408235682
OPTIC ATROPHY 11; OPA11	0.00862628	0.3282622408235682
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.00862628	0.3282622408235682
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.00862628	0.3282622408235682
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.00862253	0.32811953928790183
#613227 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME3; CAMRQ3;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 3	0.00862253	0.32811953928790183
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00862253	0.32811953928790183
COCKAYNE SYNDROME A; CSA	0.00862253	0.32811953928790183
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.00862253	0.32811953928790183
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.00862253	0.32811953928790183
GLUTATHIONURIA	0.00862253	0.32811953928790183
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.00860177	0.3273295435864526
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.00859802	0.3271868420507862
ALLAN-HERNDON-DUDLEY SYNDROME	0.0083192	0.31657669747091777
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00820579	0.3122610224949373
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.00820579	0.3122610224949373
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.00820579	0.3122610224949373
COFFIN-SIRIS SYNDROME 3; CSS3	0.00820579	0.3122610224949373
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00820579	0.3122610224949373
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.00820579	0.3122610224949373
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.00820579	0.3122610224949373
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.00820579	0.3122610224949373
COFFIN-SIRIS SYNDROME 4; CSS4	0.00820579	0.3122610224949373
PEHO-LIKE SYNDROME; PEHOL	0.00818969	0.31164835723514284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.00818969	0.31164835723514284
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.00818969	0.31164835723514284
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.00818969	0.31164835723514284
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00818969	0.31164835723514284
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00818969	0.31164835723514284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.00818969	0.31164835723514284
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.00818969	0.31164835723514284
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.00818969	0.31164835723514284
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.00818969	0.31164835723514284
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.00818969	0.31164835723514284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.00818969	0.31164835723514284
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.00811517	0.30881259231838015
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.00811517	0.30881259231838015
BARDET-BIEDL SYNDROME 1; BBS1	0.00799939	0.30440672997185847
Aarskog-Scott syndrome	0.0076422	0.2908143135652765
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.00761769	0.28988161632816084
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.00761769	0.28988161632816084
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.00761769	0.28988161632816084
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00761769	0.28988161632816084
OROFACIODIGITAL SYNDROME IV; OFD4	0.00761769	0.28988161632816084
ELSAHY-WATERS SYNDROME; ESWS	0.00761769	0.28988161632816084
%157700 MITRAL VALVE PROLAPSE 1; MVP1;;MITRAL VALVE PROLAPSE, MYXOMATOUS 1; MMVP1;;MYXOMATOUS MITRAL VALVE PROLAPSE 1;;MITRAL VALVE PROLAPSE, FAMILIAL; MVP PROLAPSED MITRAL VALVE; PMV;;MITRAL REGURGITATION, FAMILIAL;;FLOPPY MITRAL VALVE;;BARLOW SYNDROME;;MYXOMATOUS VALVULAR DISEASE, FAMILIAL;;CLICK-MURMUR SYNDROME	0.00761769	0.28988161632816084
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00761769	0.28988161632816084
NEMALINE MYOPATHY 1; NEM1	0.00761769	0.28988161632816084
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00761769	0.28988161632816084
NOONAN SYNDROME 3; NS3	0.00761769	0.28988161632816084
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00761769	0.28988161632816084
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.00761769	0.28988161632816084
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00761769	0.28988161632816084
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.00761769	0.28988161632816084
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00761769	0.28988161632816084
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00761769	0.28988161632816084
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00761769	0.28988161632816084
MENTAL RETARDATION, X-LINKED 101; MRX101	0.007512690000000001	0.2858859733295016
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.007512690000000001	0.2858859733295016
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.007512690000000001	0.2858859733295016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.007512690000000001	0.2858859733295016
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.007512690000000001	0.2858859733295016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.007512690000000001	0.2858859733295016
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.007512690000000001	0.2858859733295016
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.007512690000000001	0.2858859733295016
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.007512690000000001	0.2858859733295016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.007512690000000001	0.2858859733295016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.0074881800000000005	0.28495327609238597
CHROMOSOME 1p35 DELETION SYNDROME	0.0074881800000000005	0.28495327609238597
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0074881800000000005	0.28495327609238597
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.0074881800000000005	0.28495327609238597
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.0074881800000000005	0.28495327609238597
MENTAL RETARDATION, X-LINKED 91; MRX91	0.0074881800000000005	0.28495327609238597
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.00732693	0.2788171100587306
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00724856	0.27583483823201704
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.00724856	0.27583483823201704
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.00724856	0.27583483823201704
CEREBELLAR HYPOPLASIA	0.00724856	0.27583483823201704
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.00724856	0.27583483823201704
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00724856	0.27583483823201704
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00724856	0.27583483823201704
PEROXISOME BIOGENESIS DISORDER 5B	0.00724856	0.27583483823201704
METHYLMALONIC ACIDURIA, CBLA TYPE	0.00724856	0.27583483823201704
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00724856	0.27583483823201704
CHROMOSOME Xq26.3 DUPLICATION SYNDROME	0.0070922	0.26988475500087067
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.0070922	0.26988475500087067
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.0070922	0.26988475500087067
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.0070922	0.26988475500087067
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.0070922	0.26988475500087067
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0070922	0.26988475500087067
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.0070922	0.26988475500087067
NF1-microdeletion syndrome	0.0070922	0.26988475500087067
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.0070922	0.26988475500087067
BECKWITH-WIEDEMANN SYNDROME	0.0070922	0.26988475500087067
HYALINE FIBROMATOSIS SYNDROME; HFS	0.0070922	0.26988475500087067
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0070922	0.26988475500087067
FOUNTAIN SYNDROME	0.0070922	0.26988475500087067
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.0070922	0.26988475500087067
CHROMOSOME 2q37 DELETION SYNDROME	0.0070922	0.26988475500087067
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.0070922	0.26988475500087067
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.0070922	0.26988475500087067
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0070922	0.26988475500087067
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.0070922	0.26988475500087067
268650 RUDIGER SYNDROME	0.0070922	0.26988475500087067
#277950 WINCHESTER SYNDROME; WNCHRS	0.0070922	0.26988475500087067
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.0070922	0.26988475500087067
CHOPS SYNDROME; CHOPS	0.0070922	0.26988475500087067
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.0070922	0.26988475500087067
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.0070922	0.26988475500087067
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.0070922	0.26988475500087067
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.0070922	0.26988475500087067
SCHINDLER DISEASE, TYPE I	0.006765709999999999	0.2574605884996109
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.006765709999999999	0.2574605884996109
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.006765709999999999	0.2574605884996109
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.006765709999999999	0.2574605884996109
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.006765709999999999	0.2574605884996109
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.006765709999999999	0.2574605884996109
LEIGH SYNDROME; LS	0.006765709999999999	0.2574605884996109
LISSENCEPHALY, X-LINKED, 2	0.006741199999999999	0.2565278912624953
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.006741199999999999	0.2565278912624953
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.006649930000000001	0.2530547261530893
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.006649930000000001	0.2530547261530893
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.006649930000000001	0.2530547261530893
ADENYLOSUCCINASE DEFICIENCY	0.00664993	0.25305472615308927
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.00664993	0.25305472615308927
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.00664993	0.25305472615308927
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.00664993	0.25305472615308927
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00664993	0.25305472615308927
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00664993	0.25305472615308927
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.00664993	0.25305472615308927
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.00664993	0.25305472615308927
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00664993	0.25305472615308927
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.00664993	0.25305472615308927
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.00664993	0.25305472615308927
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.00664993	0.25305472615308927
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.00664993	0.25305472615308927
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.00664993	0.25305472615308927
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.006625420000000001	0.25212202891597374
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.006625420000000001	0.25212202891597374
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.006625420000000001	0.25212202891597374
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.00662542	0.2521220289159737
TEMPLE SYNDROME	0.00662542	0.2521220289159737
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00662542	0.2521220289159737
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00662542	0.2521220289159737
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.00662542	0.2521220289159737
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.00662542	0.2521220289159737
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0062682300000000005	0.2385296125093917
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.0062682300000000005	0.2385296125093917
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.0062682300000000005	0.2385296125093917
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.0062682300000000005	0.2385296125093917
Cerebral creatine deficiency syndrome 2	0.0062133399999999995	0.2364408425646639
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.0062133399999999995	0.2364408425646639
224550 DYSTONIA WITH RINGBINDEN	0.0062133399999999995	0.2364408425646639
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.0062133399999999995	0.2364408425646639
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.0062133399999999995	0.2364408425646639
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.0062133399999999995	0.2364408425646639
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.0062133399999999995	0.2364408425646639
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.0062133399999999995	0.2364408425646639
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.00613872	0.23360127227361674
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.00613872	0.23360127227361674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.00613872	0.23360127227361674
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.00613872	0.23360127227361674
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.00613872	0.23360127227361674
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.00613872	0.23360127227361674
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.00613872	0.23360127227361674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.00613872	0.23360127227361674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.00613872	0.23360127227361674
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.00613872	0.23360127227361674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.00613872	0.23360127227361674
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.00613872	0.23360127227361674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.00613872	0.23360127227361674
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00613872	0.23360127227361674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.00613872	0.23360127227361674
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.00613872	0.23360127227361674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.00613872	0.23360127227361674
IMMUNODEFICIENCY 49; IMD49	0.00613872	0.23360127227361674
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.00613872	0.23360127227361674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00613872	0.23360127227361674
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.00613872	0.23360127227361674
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.00613872	0.23360127227361674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.00613872	0.23360127227361674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00613872	0.23360127227361674
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.00613872	0.23360127227361674
AICARDI-GOUTIERES SYNDROME 7	0.00613872	0.23360127227361674
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.00613872	0.23360127227361674
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.00613872	0.23360127227361674
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.00613872	0.23360127227361674
AL-RAQAD SYNDROME; ARS	0.00613872	0.23360127227361674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.00613872	0.23360127227361674
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.00613872	0.23360127227361674
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.00613872	0.23360127227361674
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.00613872	0.23360127227361674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.00613872	0.23360127227361674
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.00613872	0.23360127227361674
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.00613872	0.23360127227361674
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00613872	0.23360127227361674
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.00613872	0.23360127227361674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.00613872	0.23360127227361674
#608768 SPINOCEREBELLAR ATAXIA 8; SCA8	0.00613497	0.23345857073795037
DYSTONIA 13, TORSION	0.00613497	0.23345857073795037
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00613497	0.23345857073795037
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00613497	0.23345857073795037
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.00613497	0.23345857073795037
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.00613497	0.23345857073795037
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.00613497	0.23345857073795037
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00613497	0.23345857073795037
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00613497	0.23345857073795037
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.00613497	0.23345857073795037
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00613497	0.23345857073795037
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00613497	0.23345857073795037
SPASTIC PARAPARESIS AND DEAFNESS	0.00613497	0.23345857073795037
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00613497	0.23345857073795037
AICARDI-GOUTIERES SYNDROME 6	0.00613497	0.23345857073795037
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.00613497	0.23345857073795037
PARKINSON DISEASE 21; PARK21	0.00613497	0.23345857073795037
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00613497	0.23345857073795037
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00613497	0.23345857073795037
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00613497	0.23345857073795037
#158580 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A;;HMN VIIA;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA;;DHMN7A;;DHMNVP;;SPINAL MUSCULAR ATROPHY, DISTAL, WITH VOCAL CORD PARALYSIS;;HARPER-YOUNG MYOPATHY	0.00613497	0.23345857073795037
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.00613497	0.23345857073795037
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.00613497	0.23345857073795037
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00613497	0.23345857073795037
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.00613497	0.23345857073795037
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00613497	0.23345857073795037
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00613497	0.23345857073795037
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.00613497	0.23345857073795037
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00613497	0.23345857073795037
#276880 UROCANASE DEFICIENCY	0.00613497	0.23345857073795037
#274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIAL;;UPSHAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	0.00613497	0.23345857073795037
OPTIC ATROPHY 2	0.00613497	0.23345857073795037
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.00613497	0.23345857073795037
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.00613497	0.23345857073795037
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.00613497	0.23345857073795037
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00613497	0.23345857073795037
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00613497	0.23345857073795037
MYOCLONIC-ATONIC EPILEPSY	0.00613497	0.23345857073795037
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.00613497	0.23345857073795037
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00613497	0.23345857073795037
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.00613497	0.23345857073795037
#610297 PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK13	0.00613497	0.23345857073795037
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00613497	0.23345857073795037
MYOPATHY, SPHEROID BODY	0.00613497	0.23345857073795037
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00613497	0.23345857073795037
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.00613497	0.23345857073795037
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00613497	0.23345857073795037
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00613497	0.23345857073795037
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.00613497	0.23345857073795037
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.00613497	0.23345857073795037
DYSTONIA 3, TORSION, X-LINKED	0.00613497	0.23345857073795037
WILSON DISEASE	0.00613497	0.23345857073795037
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00613497	0.23345857073795037
SNEDDON SYNDROME	0.00613497	0.23345857073795037
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.00613497	0.23345857073795037
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.00613497	0.23345857073795037
#176500 CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1;;DEMENTIA, FAMILIAL BRITISH; FBD;;PRESENILE DEMENTIA WITH SPASTIC ATAXIA;;CEREBRAL AMYLOID ANGIOPATHY, BRITISH TYPE	0.00613497	0.23345857073795037
SPINOCEREBELLAR ATAXIA 18	0.00613497	0.23345857073795037
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00613497	0.23345857073795037
PERRY SYNDROME	0.00613497	0.23345857073795037
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.00613497	0.23345857073795037
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00613497	0.23345857073795037
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.00613497	0.23345857073795037
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.00613497	0.23345857073795037
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00613497	0.23345857073795037
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.00613497	0.23345857073795037
ACROCALLOSAL SYNDROME; ACLS	0.0060642000000000005	0.23076550735685403
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.0060642000000000005	0.23076550735685403
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0060642000000000005	0.23076550735685403
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0060642000000000005	0.23076550735685403
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.0060642000000000005	0.23076550735685403
KABUKI SYNDROME 1	0.0060642000000000005	0.23076550735685403
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0060642000000000005	0.23076550735685403
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.0060642000000000005	0.23076550735685403
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0060642000000000005	0.23076550735685403
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0060642000000000005	0.23076550735685403
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.00565212	0.21508432100554425
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.00565212	0.21508432100554425
SPASTIC PARAPLEGIA 16, X-LINKED	0.00565212	0.21508432100554425
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00565212	0.21508432100554425
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00565212	0.21508432100554425
GAUCHER DISEASE, TYPE II	0.00565212	0.21508432100554425
HYPEREKPLEXIA 4; HKPX4	0.00562761	0.21415162376842864
NEMALINE MYOPATHY 3; NEM3	0.00562761	0.21415162376842864
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.00562761	0.21415162376842864
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00562761	0.21415162376842864
Pierpont syndrome	0.005536340000000001	0.21067845865902265
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.005536340000000001	0.21067845865902265
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.005536340000000001	0.21067845865902265
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.005536340000000001	0.21067845865902265
CHROMOSOME 19p13.13 DELETION SYNDROME	0.005536340000000001	0.21067845865902265
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.005536340000000001	0.21067845865902265
CHROMOSOME 3q13.31 DELETION SYNDROME	0.005536340000000001	0.21067845865902265
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.005536340000000001	0.21067845865902265
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.005536340000000001	0.21067845865902265
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.005536340000000001	0.21067845865902265
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.005536340000000001	0.21067845865902265
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.005536340000000001	0.21067845865902265
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.0055118300000000005	0.209745761421907
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.0055118300000000005	0.209745761421907
GLASS SYNDROME	0.0055118300000000005	0.209745761421907
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0055118300000000005	0.209745761421907
CHROMOSOME 17q12 DELETION SYNDROME	0.0055118300000000005	0.209745761421907
HYPOGLOSSIA WITH SITUS INVERSUS	0.0055118300000000005	0.209745761421907
DIGEORGE SYNDROME; DGS	0.0055118300000000005	0.209745761421907
MOEBIUS SYNDROME; MBS	0.0055118300000000005	0.209745761421907
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.00515464	0.196153345015325
AYME-GRIPP SYNDROME; AYGRP	0.00515464	0.196153345015325
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00515464	0.196153345015325
LYMPHEDEMA, HEREDITARY, III	0.00515464	0.196153345015325
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00515464	0.196153345015325
227320 FACIOTHORACOGENITAL SYNDROME	0.00515464	0.196153345015325
LICHTENSTEIN SYNDROME	0.00515464	0.196153345015325
CHROMOSOME 15q25 DELETION SYNDROME	0.00515464	0.196153345015325
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.00515464	0.196153345015325
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00515464	0.196153345015325
ACROCRANIOFACIAL DYSOSTOSIS	0.00515464	0.196153345015325
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00515464	0.196153345015325
STICKLER SYNDROME, TYPE I	0.00515464	0.196153345015325
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.00515464	0.196153345015325
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.00515464	0.196153345015325
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.00515464	0.196153345015325
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.00515464	0.196153345015325
GROWTH FACTORS, COMBINED DEFECT OF	0.00515464	0.196153345015325
OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO; OSFD	0.00515464	0.196153345015325
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.00515464	0.196153345015325
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.00515464	0.196153345015325
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.00515464	0.196153345015325
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.00515464	0.196153345015325
PETERS-PLUS SYNDROME; PTRPLS	0.00515464	0.196153345015325
169300 PECTUS EXCAVATUM;;FUNNEL CHEST	0.00515464	0.196153345015325
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00502513	0.1912250047795501
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.00502513	0.1912250047795501
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00502513	0.1912250047795501
OPTICOCOCHLEODENTATE DEGENERATION	0.00502513	0.1912250047795501
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.00502513	0.1912250047795501
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.00502513	0.1912250047795501
WARBURG MICRO SYNDROME 2; WARBM2	0.00502513	0.1912250047795501
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.00502513	0.1912250047795501
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.00502513	0.1912250047795501
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00502513	0.1912250047795501
MENTAL RETARDATION, X-LINKED 98; MRX98	0.00502513	0.1912250047795501
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.00502513	0.1912250047795501
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.00502513	0.1912250047795501
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.00502513	0.1912250047795501
#614970 JOUBERT SYNDROME 20; JBTS20	0.00502513	0.1912250047795501
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00502513	0.1912250047795501
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.00502513	0.1912250047795501
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.00502513	0.1912250047795501
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.00502513	0.1912250047795501
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00502513	0.1912250047795501
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00502513	0.1912250047795501
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.00502513	0.1912250047795501
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.00502513	0.1912250047795501
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00502513	0.1912250047795501
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.00502513	0.1912250047795501
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.00502513	0.1912250047795501
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.00502513	0.1912250047795501
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.00502513	0.1912250047795501
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.00502513	0.1912250047795501
LISSENCEPHALY 8; LIS8	0.00502513	0.1912250047795501
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.00502513	0.1912250047795501
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00502513	0.1912250047795501
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00502513	0.1912250047795501
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.00502513	0.1912250047795501
Congenital disorder of glycosylation, type IIh	0.00502513	0.1912250047795501
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.00502513	0.1912250047795501
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00502513	0.1912250047795501
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.00502513	0.1912250047795501
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.00502513	0.1912250047795501
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.00502513	0.1912250047795501
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.00495061	0.18838923986278733
15q26 overgrowth syndrome	0.00495061	0.18838923986278733
Muenke syndrome	0.00495061	0.18838923986278733
CHROMOSOME 16p13.3 DELETION SYNDROME	0.00495061	0.18838923986278733
OROFACIODIGITAL SYNDROME IX; OFD9	0.00495061	0.18838923986278733
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.00495061	0.18838923986278733
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00495061	0.18838923986278733
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00495061	0.18838923986278733
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.00427815	0.16279961994965944
WARBURG MICRO SYNDROME 1	0.00427815	0.16279961994965944
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.00427815	0.16279961994965944
GLYCINE ENCEPHALOPATHY; GCE	0.00427815	0.16279961994965944
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.00427815	0.16279961994965944
LESCH-NYHAN SYNDROME; LNS	0.00427815	0.16279961994965944
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.00427815	0.16279961994965944
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.00427815	0.16279961994965944
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.00427815	0.16279961994965944
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00427815	0.16279961994965944
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.00427815	0.16279961994965944
SPINOCEREBELLAR ATAXIA 1	0.00427815	0.16279961994965944
GLUTAMINE DEFICIENCY, CONGENITAL	0.00427815	0.16279961994965944
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.00427815	0.16279961994965944
SPINOCEREBELLAR ATAXIA 13	0.00427815	0.16279961994965944
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.00427815	0.16279961994965944
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.00427815	0.16279961994965944
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00427815	0.16279961994965944
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.00427815	0.16279961994965944
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.00427815	0.16279961994965944
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.00427815	0.16279961994965944
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00427815	0.16279961994965944
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00427815	0.16279961994965944
COACH SYNDROME	0.00427815	0.16279961994965944
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.00427815	0.16279961994965944
PEROXISOME BIOGENESIS DISORDER 10B	0.00427815	0.16279961994965944
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.00427815	0.16279961994965944
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.00427815	0.16279961994965944
PEHO SYNDROME; PEHO	0.00427815	0.16279961994965944
METACHROMATIC LEUKODYSTROPHY	0.00427815	0.16279961994965944
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00427815	0.16279961994965944
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00427815	0.16279961994965944
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.00427815	0.16279961994965944
GM2-GANGLIOSIDOSIS, AB VARIANT	0.00427815	0.16279961994965944
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.00427815	0.16279961994965944
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.00427815	0.16279961994965944
HYPERPROLINEMIA, TYPE I	0.00416237	0.15839375760313784
COFFIN-SIRIS SYNDROME 8; CSS8	0.00416237	0.15839375760313784
KLEEFSTRA SYNDROME 2; KLEFS2	0.00416237	0.15839375760313784
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.00416237	0.15839375760313784
COHEN-GIBSON SYNDROME; COGIS	0.00416237	0.15839375760313784
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.00416237	0.15839375760313784
SALLA DISEASE	0.00416237	0.15839375760313784
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.00416237	0.15839375760313784
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.00416237	0.15839375760313784
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00416237	0.15839375760313784
CHROMOSOME 9P DELETION SYNDROME	0.00416237	0.15839375760313784
JOUBERT SYNDROME 30; JBTS30	0.00416237	0.15839375760313784
SHASHI-PENA SYNDROME; SHAPNS	0.00416237	0.15839375760313784
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.00416237	0.15839375760313784
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00416237	0.15839375760313784
CHROMOSOME 5Q12 DELETION SYNDROME	0.00416237	0.15839375760313784
AL KAISSI SYNDROME; ALKAS	0.00416237	0.15839375760313784
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00416237	0.15839375760313784
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.00416237	0.15839375760313784
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00416237	0.15839375760313784
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.00416237	0.15839375760313784
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00416237	0.15839375760313784
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.00416237	0.15839375760313784
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00416237	0.15839375760313784
EPILEPSY, PYRIDOXINE-DEPENDENT	0.00416237	0.15839375760313784
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.00416237	0.15839375760313784
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.00416237	0.15839375760313784
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00416237	0.15839375760313784
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.00416237	0.15839375760313784
GALACTOSE EPIMERASE DEFICIENCY	0.00416237	0.15839375760313784
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.00416237	0.15839375760313784
SMITH-MAGENIS SYNDROME; SMS	0.00416237	0.15839375760313784
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.00416237	0.15839375760313784
MENTAL RETARDATION, X-LINKED 93	0.00416237	0.15839375760313784
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.00416237	0.15839375760313784
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.00416237	0.15839375760313784
MENTAL RETARDATION, X-LINKED 19	0.00416237	0.15839375760313784
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.00416237	0.15839375760313784
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.00416237	0.15839375760313784
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.00416237	0.15839375760313784
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.00416237	0.15839375760313784
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.00416237	0.15839375760313784
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.00416237	0.15839375760313784
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.00416237	0.15839375760313784
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.00360115	0.13703723604401813
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.00360115	0.13703723604401813
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.00360115	0.13703723604401813
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.00360115	0.13703723604401813
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00360115	0.13703723604401813
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00360115	0.13703723604401813
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.00360115	0.13703723604401813
CRANIOSYNOSTOSIS 6; CRS6	0.00360115	0.13703723604401813
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00360115	0.13703723604401813
ADAMS-OLIVER SYNDROME 2; AOS2	0.00360115	0.13703723604401813
JOHANSON-BLIZZARD SYNDROME; JBS	0.00360115	0.13703723604401813
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.00360115	0.13703723604401813
CYCLIC VOMITING SYNDROME	0.00360115	0.13703723604401813
JOUBERT SYNDROME 31; JBTS31	0.00360115	0.13703723604401813
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.00360115	0.13703723604401813
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00360115	0.13703723604401813
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.00360115	0.13703723604401813
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.00360115	0.13703723604401813
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.00360115	0.13703723604401813
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.00360115	0.13703723604401813
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.00360115	0.13703723604401813
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.00360115	0.13703723604401813
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.00360115	0.13703723604401813
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00360115	0.13703723604401813
BOHRING-OPITZ SYNDROME	0.00360115	0.13703723604401813
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.00360115	0.13703723604401813
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00360115	0.13703723604401813
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.00360115	0.13703723604401813
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.00360115	0.13703723604401813
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00360115	0.13703723604401813
SENGERS SYNDROME	0.00360115	0.13703723604401813
MARINESCO-SJOGREN SYNDROME; MSS	0.00360115	0.13703723604401813
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.00360115	0.13703723604401813
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00360115	0.13703723604401813
Mental retardation, autosomal dominant 21	0.00360115	0.13703723604401813
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.00360115	0.13703723604401813
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00360115	0.13703723604401813
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.00360115	0.13703723604401813
JOUBERT SYNDROME 14	0.00360115	0.13703723604401813
MENTAL RETARDATION, X-LINKED 1	0.00360115	0.13703723604401813
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00360115	0.13703723604401813
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00360115	0.13703723604401813
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00360115	0.13703723604401813
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00360115	0.13703723604401813
LATHOSTEROLOSIS	0.00357664	0.13610453880690251
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00357664	0.13610453880690251
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.00357664	0.13610453880690251
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.00357664	0.13610453880690251
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00357664	0.13610453880690251
FUMARASE DEFICIENCY; FMRD	0.00357664	0.13610453880690251
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.00357664	0.13610453880690251
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00357664	0.13610453880690251
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.00357664	0.13610453880690251
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00357664	0.13610453880690251
RING CHROMOSOME 14 SYNDROME	0.00357664	0.13610453880690251
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00357664	0.13610453880690251
OROFACIODIGITAL SYNDROME VI	0.00357664	0.13610453880690251
IMMUNODEFICIENCY 23; IMD23	0.00357664	0.13610453880690251
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00357664	0.13610453880690251
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.00357664	0.13610453880690251
ADDUCTED THUMBS SYNDROME	0.00357664	0.13610453880690251
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.00357664	0.13610453880690251
NEMALINE MYOPATHY 7; NEM7	0.00357664	0.13610453880690251
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00357664	0.13610453880690251
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00357664	0.13610453880690251
JOUBERT SYNDROME 2	0.00357664	0.13610453880690251
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.00357664	0.13610453880690251
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00357664	0.13610453880690251
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.00357664	0.13610453880690251
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.00357664	0.13610453880690251
MEND SYNDROME; MEND	0.00357664	0.13610453880690251
WARSAW BREAKAGE SYNDROME; WABS	0.00357664	0.13610453880690251
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.00357664	0.13610453880690251
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00357664	0.13610453880690251
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.00357664	0.13610453880690251
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00357664	0.13610453880690251
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00357664	0.13610453880690251
MYOPATHY, CENTRONUCLEAR, 5	0.00357664	0.13610453880690251
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00357664	0.13610453880690251
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00357664	0.13610453880690251
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.00357664	0.13610453880690251
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00357664	0.13610453880690251
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00316456	0.12042335245559278
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00316456	0.12042335245559278
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00316456	0.12042335245559278
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	0.00316456	0.12042335245559278
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00316456	0.12042335245559278
GABA-TRANSAMINASE DEFICIENCY	0.00316456	0.12042335245559278
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00316456	0.12042335245559278
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00316456	0.12042335245559278
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.00316456	0.12042335245559278
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.00316456	0.12042335245559278
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.00316456	0.12042335245559278
AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16	0.00316456	0.12042335245559278
NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D	0.00316456	0.12042335245559278
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00316456	0.12042335245559278
#615281 HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEGSPASTICITY; HBSL;;ASPARTYL-tRNA SYNTHETASE DEFICIENCY	0.00316456	0.12042335245559278
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00316456	0.12042335245559278
HARTNUP DISORDER	0.00316456	0.12042335245559278
MAST SYNDROME	0.00316456	0.12042335245559278
#602099 AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE; ALS5	0.00316456	0.12042335245559278
MICROHYDRANENCEPHALY; MHAC	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	0.00316456	0.12042335245559278
AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24	0.00316456	0.12042335245559278
#609340 SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28	0.00316456	0.12042335245559278
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	0.00316456	0.12042335245559278
#182601 SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 2; FSP2	0.00316456	0.12042335245559278
#613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	0.00316456	0.12042335245559278
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00316456	0.12042335245559278
#606070 AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21;;MYOPATHY, DISTAL, 2, FORMERLY; MPD2, FORMERLY;;VOCAL CORD AND PHARYNGEAL DYSFUNCTION WITH DISTAL MYOPATHY, FORMERLY;VCPDM, FORMERLY	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38	0.00316456	0.12042335245559278
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00316456	0.12042335245559278
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00316456	0.12042335245559278
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.00316456	0.12042335245559278
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00316456	0.12042335245559278
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00316456	0.12042335245559278
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00316456	0.12042335245559278
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.00316456	0.12042335245559278
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.00316456	0.12042335245559278
PRIMARY LATERAL SCLEROSIS, ADULT	0.00316456	0.12042335245559278
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.00316456	0.12042335245559278
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00316456	0.12042335245559278
#612020 SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39;;NTE-RELATED MOTOR NEURON DISORDER; NTEMND	0.00316456	0.12042335245559278
#182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	0.00316456	0.12042335245559278
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.00316456	0.12042335245559278
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00316456	0.12042335245559278
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.00316456	0.12042335245559278
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00316456	0.12042335245559278
SPINOCEREBELLAR ATAXIA 14	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	0.00316456	0.12042335245559278
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.00316456	0.12042335245559278
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.00316456	0.12042335245559278
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00316456	0.12042335245559278
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.00316456	0.12042335245559278
#604187 SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10;;SPASTIC PARAPLEGIA 10 WITH OR WITHOUT PERIPHERAL NEUROPATHY	0.00316456	0.12042335245559278
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	0.00316456	0.12042335245559278
HUNTINGTON DISEASE; HD	0.00316456	0.12042335245559278
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.00316456	0.12042335245559278
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.00316456	0.12042335245559278
#615625 SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE; SPG72SPASTIC PARAPLEGIA 72, AUTOSOMAL DOMINANT	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00316456	0.12042335245559278
%613364 SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41	0.00316456	0.12042335245559278
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE	0.00316456	0.12042335245559278
#221820 LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS;;LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROIDS, AUTOSOMAL DOMINANT;;GLIOSIS, FAMILIAL PROGRESSIVE SUBCORTICAL; GPSC;;DEMENTIA, FAMILIAL, NEUMANN TYPE;;SUBCORTICAL GLIOSIS OF NEUMANN	0.00316456	0.12042335245559278
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.00316456	0.12042335245559278
#607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	0.00316456	0.12042335245559278
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.00316456	0.12042335245559278
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00316456	0.12042335245559278
#270685 SPASTIC PARAPLEGIA 17; SPG17;;SPASTIC PARAPLEGIA WITH AMYOTROPHY OF HANDS AND FEET;;SILVER SYNDROME;;SILVER SPASTIC PARAPLEGIA SYNDROME	0.00316456	0.12042335245559278
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	0.00316456	0.12042335245559278
HYPEREKPLEXIA 2; HKPX2	0.00316456	0.12042335245559278
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.00316456	0.12042335245559278
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00316456	0.12042335245559278
#610357 SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE; SPG30	0.00316456	0.12042335245559278
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00316456	0.12042335245559278
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00316456	0.12042335245559278
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.00316456	0.12042335245559278
#601042 DYSTONIA 9; DYT9;;CHOREOATHETOSIS/SPASTICITY, EPISODIC;;CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA;;CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY	0.00316456	0.12042335245559278
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.00316456	0.12042335245559278
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.00316456	0.12042335245559278
#603563 SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT; SPG8	0.00316456	0.12042335245559278
AMYOTROPHIC LATERAL SCLEROSIS 1	0.00316456	0.12042335245559278
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE	0.00316456	0.12042335245559278
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00316456	0.12042335245559278
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00316456	0.12042335245559278
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00316456	0.12042335245559278
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00316456	0.12042335245559278
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.00316456	0.12042335245559278
#602433 AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4;;NEURONOPATHY, DISTAL HEREDITARY MOTOR, WITH PYRAMIDAL FEATURES	0.00316456	0.12042335245559278
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.00316456	0.12042335245559278
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00316456	0.12042335245559278
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.00316456	0.12042335245559278
#604432 SPINOCEREBELLAR ATAXIA 11; SCA11	0.00316456	0.12042335245559278
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.00316456	0.12042335245559278
#258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3;;MGA, TYPE III; MGA3;;OPTIC ATROPHY PLUS SYNDROME;;OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;;IRAQI-JEWISH 'OPTIC ATROPHY PLUS';;COSTEFF SYNDROME;;OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE;;OPA3, AUTOSOMAL RECESSIVE	0.00316456	0.12042335245559278
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.00316456	0.12042335245559278
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00316456	0.12042335245559278
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.00304878	0.11601749010907116
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.00304878	0.11601749010907116
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00304878	0.11601749010907116
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.00304878	0.11601749010907116
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.00304878	0.11601749010907116
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.00304878	0.11601749010907116
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00304878	0.11601749010907116
BARDET-BIEDL SYNDROME 21; BBS21	0.00304878	0.11601749010907116
Recurrent 16p12.1 microdeletion (neurodevelopmental susceptibility locus)	0.00304878	0.11601749010907116
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00304878	0.11601749010907116
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.00304878	0.11601749010907116
SHORT SYNDROME	0.00304878	0.11601749010907116
8p23.1 duplication syndrome	0.00304878	0.11601749010907116
SPEECH-LANGUAGE DISORDER 1	0.00304878	0.11601749010907116
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.00304878	0.11601749010907116
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.00304878	0.11601749010907116
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.00304878	0.11601749010907116
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00304878	0.11601749010907116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.00304878	0.11601749010907116
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.00304878	0.11601749010907116
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00304878	0.11601749010907116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.00304878	0.11601749010907116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.00304878	0.11601749010907116
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.00304878	0.11601749010907116
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.00304878	0.11601749010907116
22q11 deletion syndrome (Velocardiofacial / DiGeorge syndrome)	0.00304878	0.11601749010907116
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00304878	0.11601749010907116
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00304878	0.11601749010907116
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00304878	0.11601749010907116
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.00304878	0.11601749010907116
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.00304878	0.11601749010907116
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00304878	0.11601749010907116
#615328 SHAHEEN SYNDROME; SHNS	0.00304878	0.11601749010907116
AUTISM	0.00304878	0.11601749010907116
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.00304878	0.11601749010907116
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00304878	0.11601749010907116
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.00304878	0.11601749010907116
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.00304878	0.11601749010907116
FG SYNDROME 2; FGS2	0.00304878	0.11601749010907116
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00304878	0.11601749010907116
RETINITIS PIGMENTOSA 71; RP71	0.00304878	0.11601749010907116
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00304878	0.11601749010907116
Cerebral creatine deficiency syndrome 3	0.00304878	0.11601749010907116
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00304878	0.11601749010907116
BRACHYDACTYLY, TYPE A1, D	0.00304878	0.11601749010907116
22q13 deletion syndrome (Phelan-Mcdermid syndrome)	0.00304878	0.11601749010907116
Retinitis pigmentosa with or without skeletal anomalies	0.00304878	0.11601749010907116
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.00304878	0.11601749010907116
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.00304878	0.11601749010907116
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.00304878	0.11601749010907116
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00304878	0.11601749010907116
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00304878	0.11601749010907116
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00304878	0.11601749010907116
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00304878	0.11601749010907116
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.00304878	0.11601749010907116
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00304878	0.11601749010907116
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00304878	0.11601749010907116
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00304878	0.11601749010907116
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.00304878	0.11601749010907116
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00304878	0.11601749010907116
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.00304878	0.11601749010907116
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00304878	0.11601749010907116
Orofaciodigital syndrome XVII	0.00304878	0.11601749010907116
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00304878	0.11601749010907116
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.00304878	0.11601749010907116
HYPERLYSINEMIA, TYPE I	0.00304878	0.11601749010907116
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.00304878	0.11601749010907116
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00304878	0.11601749010907116
MENTAL RETARDATION, X-LINKED 95	0.00304878	0.11601749010907116
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.00304878	0.11601749010907116
7q11.23 duplication syndrome	0.00304878	0.11601749010907116
#614728 SECKEL SYNDROME 6; SCKL6	0.00304878	0.11601749010907116
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.00304878	0.11601749010907116
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.00304878	0.11601749010907116
#300705 MENTAL RETARDATION, X-LINKED 17; MRX17;;MENTAL RETARDATION, X-LINKED 31; MRX31	0.00304878	0.11601749010907116
GERODERMA OSTEODYSPLASTICUM; GO	0.00304878	0.11601749010907116
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00304878	0.11601749010907116
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.00304878	0.11601749010907116
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00304878	0.11601749010907116
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.00304878	0.11601749010907116
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00304878	0.11601749010907116
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.00304878	0.11601749010907116
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00304878	0.11601749010907116
CHROMOSOME 13q14 DELETION SYNDROME	0.00304878	0.11601749010907116
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00304878	0.11601749010907116
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.00304878	0.11601749010907116
MENTAL RETARDATION, X-LINKED 9	0.00304878	0.11601749010907116
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.00304878	0.11601749010907116
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.00304878	0.11601749010907116
ABLEPHARON-MACROSTOMIA SYNDROME	0.00304878	0.11601749010907116
CRANIOSYNOSTOSIS 7	0.00304878	0.11601749010907116
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00304878	0.11601749010907116
LIG4 SYNDROME	0.00304878	0.11601749010907116
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.00304878	0.11601749010907116
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00304878	0.11601749010907116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.00304878	0.11601749010907116
MAXILLOFACIAL DYSOSTOSIS	0.00304878	0.11601749010907116
FORSYTHE-WAKELING SYNDROME; FWS	0.00304878	0.11601749010907116
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00304878	0.11601749010907116
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00304878	0.11601749010907116
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00304878	0.11601749010907116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.00304878	0.11601749010907116
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00248756	0.09466096854995147
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00248756	0.09466096854995147
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00248756	0.09466096854995147
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00248756	0.09466096854995147
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00248756	0.09466096854995147
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00248756	0.09466096854995147
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.00248756	0.09466096854995147
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00248756	0.09466096854995147
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00248756	0.09466096854995147
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00248756	0.09466096854995147
#602398 DESMOSTEROLOSIS	0.00248756	0.09466096854995147
FANCONI ANEMIA	0.00248756	0.09466096854995147
#103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS;;WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE;WS2-OA	0.00248756	0.09466096854995147
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.00248756	0.09466096854995147
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.00248756	0.09466096854995147
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00248756	0.09466096854995147
#610427 CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B, FORMERLY; CSNB2B,FORMERLY;;NIGHT BLINDNESS, CONGENITAL STATIONARY, INCOMPLETE, AUTOSOMAL RECESSIVE,FORMERLY	0.00248756	0.09466096854995147
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00248756	0.09466096854995147
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00248756	0.09466096854995147
GLYCEROL KINASE DEFICIENCY; GKD	0.00248756	0.09466096854995147
CROUZON SYNDROME	0.00248756	0.09466096854995147
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00248756	0.09466096854995147
LAMBOTTE SYNDROME	0.00248756	0.09466096854995147
MASA SYNDROME	0.00248756	0.09466096854995147
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00248756	0.09466096854995147
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00248756	0.09466096854995147
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00248756	0.09466096854995147
HYPERTRYPTOPHANEMIA; HYPTRP	0.00248756	0.09466096854995147
BAKER-GORDON SYNDROME; BAGOS	0.00248756	0.09466096854995147
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.00248756	0.09466096854995147
Rothmund-Thomson syndrome	0.00248756	0.09466096854995147
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00248756	0.09466096854995147
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00248756	0.09466096854995147
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.00248756	0.09466096854995147
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.00248756	0.09466096854995147
#610048 CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD;;CONGENITAL STROMAL CORNEAL DYSTROPHY	0.00248756	0.09466096854995147
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00248756	0.09466096854995147
CHAR SYNDROME	0.00248756	0.09466096854995147
IVIC SYNDROME	0.00248756	0.09466096854995147
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00248756	0.09466096854995147
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.00248756	0.09466096854995147
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.00248756	0.09466096854995147
HEMIFACIAL MICROSOMIA	0.00248756	0.09466096854995147
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00248756	0.09466096854995147
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00248756	0.09466096854995147
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00248756	0.09466096854995147
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00248756	0.09466096854995147
NEPHRONOPHTHISIS 11; NPHP11	0.00248756	0.09466096854995147
RETINAL CONE DYSTROPHY 3B	0.00248756	0.09466096854995147
OCULOECTODERMAL SYNDROME; OES	0.00248756	0.09466096854995147
VITREORETINOCHOROIDOPATHY; VRCP	0.00248756	0.09466096854995147
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.00248756	0.09466096854995147
RICHARDS-RUNDLE SYNDROME; RRNS	0.00248756	0.09466096854995147
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00248756	0.09466096854995147
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.00248756	0.09466096854995147
#614199 NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES;NPHS5	0.00248756	0.09466096854995147
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00248756	0.09466096854995147
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.00248756	0.09466096854995147
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00248756	0.09466096854995147
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.00248756	0.09466096854995147
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00248756	0.09466096854995147
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00248756	0.09466096854995147
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00248756	0.09466096854995147
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.00248756	0.09466096854995147
#615058 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F; CSNB1F	0.00248756	0.09466096854995147
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.00248756	0.09466096854995147
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.00248756	0.09466096854995147
LEBER CONGENITAL AMAUROSIS 16	0.00248756	0.09466096854995147
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.00248756	0.09466096854995147
NEPHRONOPHTHISIS 18; NPHP18	0.00248756	0.09466096854995147
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.00248756	0.09466096854995147
CHANARIN-DORFMAN SYNDROME	0.00248756	0.09466096854995147
SENIOR-LOKEN SYNDROME 9	0.00248756	0.09466096854995147
#613216 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.00248756	0.09466096854995147
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00248756	0.09466096854995147
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.00248756	0.09466096854995147
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00248756	0.09466096854995147
DUANE-RADIAL RAY SYNDROME; DRRS	0.00248756	0.09466096854995147
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00248756	0.09466096854995147
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00248756	0.09466096854995147
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.00248756	0.09466096854995147
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.00248756	0.09466096854995147
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00248756	0.09466096854995147
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.00248756	0.09466096854995147
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00248756	0.09466096854995147
#608470 CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE I; CDB1;;CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE; CDRB;;REIS-BUCKLERS CORNEAL DYSTROPHY; RBCD;;CORNEAL DYSTROPHY, GEOGRAPHIC;;GRANULAR CORNEAL DYSTROPHY, TYPE III	0.00248756	0.09466096854995147
ABDUCENS PALSY	0.00248756	0.09466096854995147
ROBINOW-SORAUF SYNDROME	0.00248756	0.09466096854995147
BRANCHIOOCULOFACIAL SYNDROME	0.00248756	0.09466096854995147
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00248756	0.09466096854995147
#129500 CLOUSTON SYNDROME;;ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;;ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;;CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;;ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY	0.00248756	0.09466096854995147
PELGER-HUET ANOMALY; PHA	0.00248756	0.09466096854995147
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00248756	0.09466096854995147
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.00248756	0.09466096854995147
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00248756	0.09466096854995147
RAHMAN SYNDROME	0.00248756	0.09466096854995147
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00248756	0.09466096854995147
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00248756	0.09466096854995147
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.00248756	0.09466096854995147
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00248756	0.09466096854995147
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.00248756	0.09466096854995147
PETERS ANOMALY	0.00248756	0.09466096854995147
3MC SYNDROME 2	0.00248756	0.09466096854995147
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.00248756	0.09466096854995147
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00248756	0.09466096854995147
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00248756	0.09466096854995147
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.00248756	0.09466096854995147
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.00248756	0.09466096854995147
GAUCHER DISEASE, TYPE IIIC	0.00248756	0.09466096854995147
OPTIC ATROPHY 1; OPA1	0.00248756	0.09466096854995147
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.00248756	0.09466096854995147
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.00248756	0.09466096854995147
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00248756	0.09466096854995147
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00248756	0.09466096854995147
THAUVIN-ROBINET-FAIVRE SYNDROME	0.00248756	0.09466096854995147
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.00246305	0.09372827131283586
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00246305	0.09372827131283586
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00246305	0.09372827131283586
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.00246305	0.09372827131283586
PERRAULT SYNDROME 5; PRLTS5	0.00246305	0.09372827131283586
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00246305	0.09372827131283586
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00246305	0.09372827131283586
#601462 MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL; SCCMS;;MYASTHENIC SYNDROME, CONGENITAL, POSTSYNAPTIC SLOW-CHANNEL;;MYASTHENIC SYNDROME, CONGENITAL, TYPE IIa; CMS2A;;CMS IIa	0.00246305	0.09372827131283586
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00246305	0.09372827131283586
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00246305	0.09372827131283586
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00246305	0.09372827131283586
ALAZAMI-YUAN SYNDROME	0.00246305	0.09372827131283586
BRANCHIOOTORENAL SYNDROME 1	0.00246305	0.09372827131283586
#612292 BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME;;BIRK-BAREL SYNDROME;;MENTAL RETARDATION WITH HYPOTONIA AND FACIAL DYSMORPHISM	0.00246305	0.09372827131283586
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.00246305	0.09372827131283586
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.00246305	0.09372827131283586
HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.00246305	0.09372827131283586
601095 HARROD SYNDROME	0.00246305	0.09372827131283586
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.00246305	0.09372827131283586
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00246305	0.09372827131283586
LERI-WEILL DYSCHONDROSTEOSIS	0.00246305	0.09372827131283586
NASODIGITOACOUSTIC SYNDROME	0.00246305	0.09372827131283586
EVEN-PLUS SYNDROME	0.00246305	0.09372827131283586
#610313 COLD-INDUCED SWEATING SYNDROME 2; CISS2	0.00246305	0.09372827131283586
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.00246305	0.09372827131283586
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00246305	0.09372827131283586
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00246305	0.09372827131283586
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00246305	0.09372827131283586
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.00246305	0.09372827131283586
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00246305	0.09372827131283586
#613611 CHOANAL ATRESIA AND LYMPHEDEMA	0.00246305	0.09372827131283586
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.00246305	0.09372827131283586
CHROMOSOME 18P DELETION SYNDROME	0.00246305	0.09372827131283586
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00246305	0.09372827131283586
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00246305	0.09372827131283586
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.00246305	0.09372827131283586
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00246305	0.09372827131283586
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00246305	0.09372827131283586
Ullrich congenital muscular dystrophy 1	0.00246305	0.09372827131283586
CORNELIA DE LANGE SYNDROME 3	0.00246305	0.09372827131283586
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00246305	0.09372827131283586
MYOPATHY, DISTAL, 1; MPD1	0.00246305	0.09372827131283586
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00246305	0.09372827131283586
#616470 ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2	0.00246305	0.09372827131283586
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.00246305	0.09372827131283586
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00246305	0.09372827131283586
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.00246305	0.09372827131283586
NEU-LAXOVA SYNDROME 2; NLS2	0.00246305	0.09372827131283586
#255160 MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB;;MYOPATHY, HYALINE BODY, AUTOSOMAL RECESSIVE	0.00246305	0.09372827131283586
#246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3;;SHSF3;;LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;;CHROMOSOME 10Q24 DUPLICATION SYNDROME	0.00246305	0.09372827131283586
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00246305	0.09372827131283586
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.00246305	0.09372827131283586
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00246305	0.09372827131283586
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00246305	0.09372827131283586
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.00246305	0.09372827131283586
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00246305	0.09372827131283586
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.00246305	0.09372827131283586
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.00246305	0.09372827131283586
OROFACIODIGITAL SYNDROME I; OFD1	0.00246305	0.09372827131283586
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.00246305	0.09372827131283586
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00246305	0.09372827131283586
CEREBROOCULONASAL SYNDROME	0.00246305	0.09372827131283586
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.00246305	0.09372827131283586
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00246305	0.09372827131283586
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00246305	0.09372827131283586
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00246305	0.09372827131283586
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.00246305	0.09372827131283586
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.00246305	0.09372827131283586
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00246305	0.09372827131283586
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00246305	0.09372827131283586
608028 THAI SYMPHALANGISM SYNDROME	0.00246305	0.09372827131283586
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00246305	0.09372827131283586
MENTAL RETARDATION, X-LINKED 45	0.00246305	0.09372827131283586
MENTAL RETARDATION, X-LINKED 2	0.00246305	0.09372827131283586
FEINGOLD SYNDROME 1; FGLDS1	0.00246305	0.09372827131283586
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00246305	0.09372827131283586
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00246305	0.09372827131283586
#613506 AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5;;AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT	0.00246305	0.09372827131283586
HOLOPROSENCEPHALY 5; HPE5	0.00246305	0.09372827131283586
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.00246305	0.09372827131283586
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00246305	0.09372827131283586
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00246305	0.09372827131283586
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.00111359	0.04237626749406666
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.00111359	0.04237626749406666
MEVALONIC ACIDURIA; MEVA	0.00111359	0.04237626749406666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.00111359	0.04237626749406666
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.00111359	0.04237626749406666
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00111359	0.04237626749406666
HOLOPROSENCEPHALY 2; HPE2	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.00111359	0.04237626749406666
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.00111359	0.04237626749406666
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.00111359	0.04237626749406666
JOUBERT SYNDROME 6	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.00111359	0.04237626749406666
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.00111359	0.04237626749406666
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.00111359	0.04237626749406666
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.00111359	0.04237626749406666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.00111359	0.04237626749406666
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.00111359	0.04237626749406666
JOUBERT SYNDROME 32; JBTS32	0.00111359	0.04237626749406666
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.00111359	0.04237626749406666
TAY-SACHS DISEASE; TSD	0.00111359	0.04237626749406666
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.00111359	0.04237626749406666
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.00111359	0.04237626749406666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.00111359	0.04237626749406666
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00111359	0.04237626749406666
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.00111359	0.04237626749406666
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00111359	0.04237626749406666
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.00111359	0.04237626749406666
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00111359	0.04237626749406666
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.00111359	0.04237626749406666
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.00111359	0.04237626749406666
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.00111359	0.04237626749406666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.00111359	0.04237626749406666
PSEUDO-TORCH SYNDROME 2	0.00111359	0.04237626749406666
PORPHYRIA, ACUTE HEPATIC	0.00111359	0.04237626749406666
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.00111359	0.04237626749406666
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.00111359	0.04237626749406666
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00111359	0.04237626749406666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.00111359	0.04237626749406666
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00111359	0.04237626749406666
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.00111359	0.04237626749406666
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.00111359	0.04237626749406666
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00111359	0.04237626749406666
GLYCOGEN STORAGE DISEASE IV	0.00111359	0.04237626749406666
EPILEPSY, HOT WATER, 1	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.00111359	0.04237626749406666
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00111359	0.04237626749406666
VICI SYNDROME; VICIS	0.00111359	0.04237626749406666
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00111359	0.04237626749406666
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00111359	0.04237626749406666
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00111359	0.04237626749406666
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00111359	0.04237626749406666
HOLOPROSENCEPHALY 1; HPE1	0.00111359	0.04237626749406666
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.00111359	0.04237626749406666
JOUBERT SYNDROME 7	0.00111359	0.04237626749406666
ARIMA SYNDROME	0.00111359	0.04237626749406666
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.00111359	0.04237626749406666
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00111359	0.04237626749406666
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.00111359	0.04237626749406666
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00111359	0.04237626749406666
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00111359	0.04237626749406666
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00111359	0.04237626749406666
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00111359	0.04237626749406666
XYLOSIDASE DEFICIENCY	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.00111359	0.04237626749406666
TEMPLE-BARAITSER SYNDROME; TMBTS	0.00111359	0.04237626749406666
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00111359	0.04237626749406666
HYPERCALCEMIA, INFANTILE, 1	0.00111359	0.04237626749406666
Mulchandani-Bhoj-Conlin syndrome	0.00111359	0.04237626749406666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.00111359	0.04237626749406666
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00111359	0.04237626749406666
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00111359	0.04237626749406666
GLYCOGEN STORAGE DISEASE IXC	0.00111359	0.04237626749406666
CHROMOSOME 4q21 DELETION SYNDROME	0.00111359	0.04237626749406666
EPISODIC ATAXIA, TYPE 6	0.00111359	0.04237626749406666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.00111359	0.04237626749406666
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.00111359	0.04237626749406666
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.00111359	0.04237626749406666
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.00111359	0.04237626749406666
INFANTILE LIVER FAILURE SYNDROME 1	0.00111359	0.04237626749406666
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00111359	0.04237626749406666
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00111359	0.04237626749406666
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00111359	0.04237626749406666
JOUBERT SYNDROME 8	0.00111359	0.04237626749406666
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.00111359	0.04237626749406666
OHDO SYNDROME	0.00111359	0.04237626749406666
JOUBERT SYNDROME 3; JBTS3	0.00111359	0.04237626749406666
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.00111359	0.04237626749406666
LISSENCEPHALY 5; LIS5	0.00111359	0.04237626749406666
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00111359	0.04237626749406666
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.00111359	0.04237626749406666
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00111359	0.04237626749406666
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00111359	0.04237626749406666
JOUBERT SYNDROME 1	0.00111359	0.04237626749406666
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.00111359	0.04237626749406666
ACID PHOSPHATASE DEFICIENCY	0.00111359	0.04237626749406666
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.00111359	0.04237626749406666
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.00111359	0.04237626749406666
JOUBERT SYNDROME 28	0.00111359	0.04237626749406666
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00111359	0.04237626749406666
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.00111359	0.04237626749406666
ADAMS-OLIVER SYNDROME 1; AOS1	0.00111359	0.04237626749406666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.00111359	0.04237626749406666
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.00111359	0.04237626749406666
COFFIN-SIRIS SYNDROME 10; CSS10	0.00111359	0.04237626749406666
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.00111359	0.04237626749406666
OSTEOPENIA AND SPARSE HAIR	0.00111359	0.04237626749406666
JOUBERT SYNDROME 27	0.00111359	0.04237626749406666
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.00111359	0.04237626749406666
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.00111359	0.04237626749406666
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.00111359	0.04237626749406666
GLYCOGEN STORAGE DISEASE IXB	0.00111359	0.04237626749406666
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.00111359	0.04237626749406666
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00111359	0.04237626749406666
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.00111359	0.04237626749406666
ELEJALDE DISEASE	0.00111359	0.04237626749406666
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.00111359	0.04237626749406666
MENTAL RETARDATION, X-LINKED 102	0.00111359	0.04237626749406666
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00111359	0.04237626749406666
JOUBERT SYNDROME 15	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.00111359	0.04237626749406666
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00111359	0.04237626749406666
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00111359	0.04237626749406666
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00111359	0.04237626749406666
PIERSON SYNDROME	0.00111359	0.04237626749406666
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.00111359	0.04237626749406666
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.00111359	0.04237626749406666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.00111359	0.04237626749406666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.00111359	0.04237626749406666
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00111359	0.04237626749406666
LISSENCEPHALY 3; LIS3	0.00111359	0.04237626749406666
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.00111359	0.04237626749406666
MENTAL RETARDATION, X-LINKED 41	0.00111359	0.04237626749406666
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.00111359	0.04237626749406666
XIA-GIBBS SYNDROME	0.00111359	0.04237626749406666
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.00111359	0.04237626749406666
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.00111359	0.04237626749406666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.00111359	0.04237626749406666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.00111359	0.04237626749406666
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.00111359	0.04237626749406666
NOONAN SYNDROME 11; NS11	0.00111359	0.04237626749406666
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.00111359	0.04237626749406666
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00111359	0.04237626749406666
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.00111359	0.04237626749406666
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.00111359	0.04237626749406666
JOUBERT SYNDROME 35; JBTS35	0.00111359	0.04237626749406666
LARSEN-LIKE SYNDROME	0.00111359	0.04237626749406666
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.00111359	0.04237626749406666
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.00111359	0.04237626749406666
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.00111359	0.04237626749406666
MENKES DISEASE	0.00111359	0.04237626749406666
ZUNICH NEUROECTODERMAL SYNDROME	0.00111359	0.04237626749406666
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.00111359	0.04237626749406666
ROIFMAN SYNDROME; RFMN	0.00111359	0.04237626749406666
GRISCELLI SYNDROME, TYPE 1	0.00111359	0.04237626749406666
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.00111359	0.04237626749406666
JOUBERT SYNDROME 25	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.00111359	0.04237626749406666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00111359	0.04237626749406666
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.00111359	0.04237626749406666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00111359	0.04237626749406666
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00111359	0.04237626749406666
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00111359	0.04237626749406666
LIVER FAILURE, INFANTILE, TRANSIENT	0.00111359	0.04237626749406666
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.00111359	0.04237626749406666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.00111359	0.04237626749406666
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.00111359	0.04237626749406666
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.00111359	0.04237626749406666
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00111359	0.04237626749406666
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.00111359	0.04237626749406666
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.00111359	0.04237626749406666
OROFACIODIGITAL SYNDROME XVI; OFD16	0.00111359	0.04237626749406666
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00111359	0.04237626749406666
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.00111359	0.04237626749406666
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.00111359	0.04237626749406666
NIEMANN-PICK DISEASE, TYPE C2	0.00111359	0.04237626749406666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.00111359	0.04237626749406666
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00111359	0.04237626749406666
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00111359	0.04237626749406666
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.00111359	0.04237626749406666
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.00111359	0.04237626749406666
JOUBERT SYNDROME 4	0.00111359	0.04237626749406666
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00111359	0.04237626749406666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.00111359	0.04237626749406666
PEROXISOME BIOGENESIS DISORDER 11B	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.00111359	0.04237626749406666
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.00111359	0.04237626749406666
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.00111359	0.04237626749406666
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.00111359	0.04237626749406666
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00111359	0.04237626749406666
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00111359	0.04237626749406666
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00111359	0.04237626749406666
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.00111359	0.04237626749406666
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.00111359	0.04237626749406666
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.00111359	0.04237626749406666
EHLERS-DANLOS SYNDROME, TYPE VI	0.00111359	0.04237626749406666
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.00111359	0.04237626749406666
JOUBERT SYNDROME 26	0.00111359	0.04237626749406666
PEROXISOME BIOGENESIS DISORDER 3B	0.00111359	0.04237626749406666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00111359	0.04237626749406666
FONTAINE PROGEROID SYNDROME; FPS	0.00111359	0.04237626749406666
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.00111359	0.04237626749406666
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00111359	0.04237626749406666
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.00111359	0.04237626749406666
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.00111359	0.04237626749406666
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.00111359	0.04237626749406666
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.00111359	0.04237626749406666
NEMALINE MYOPATHY 10	0.00111359	0.04237626749406666
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.00111359	0.04237626749406666
FOLATE MALABSORPTION, HEREDITARY	0.00111359	0.04237626749406666
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00111359	0.04237626749406666
MENTAL RETARDATION, X-LINKED 99	0.00111359	0.04237626749406666
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.00111359	0.04237626749406666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.00111359	0.04237626749406666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.00111359	0.04237626749406666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00111359	0.04237626749406666
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00111359	0.04237626749406666
VISCERAL STEATOSIS, CONGENITAL	0.00111359	0.04237626749406666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.00111359	0.04237626749406666
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.00111359	0.04237626749406666
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.00111359	0.04237626749406666
CHIARI MALFORMATION TYPE II	0.00111359	0.04237626749406666
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00111359	0.04237626749406666
SUDDEN CARDIAC FAILURE, INFANTILE	0.00111359	0.04237626749406666
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.00111359	0.04237626749406666
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.00111359	0.04237626749406666
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00111359	0.04237626749406666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.00111359	0.04237626749406666
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00111359	0.04237626749406666
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00111359	0.04237626749406666
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.00111359	0.04237626749406666
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.00111359	0.04237626749406666
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.00111359	0.04237626749406666
NAVAJO NEUROHEPATOPATHY	0.00111359	0.04237626749406666
TIMOTHY SYNDROME; TS	0.00111359	0.04237626749406666
METHYLMALONIC ACIDURIA, CBLB TYPE	0.00111359	0.04237626749406666
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00111359	0.04237626749406666
MYOTONIC DYSTROPHY 1	0.00111359	0.04237626749406666
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.00111359	0.04237626749406666
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00111359	0.04237626749406666
GLUTARIC ACIDEMIA I; GA1	0.00111359	0.04237626749406666
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.00111359	0.04237626749406666
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.00111359	0.04237626749406666
MAPLE SYRUP URINE DISEASE; MSUD	0.00111359	0.04237626749406666
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00111359	0.04237626749406666
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00111359	0.04237626749406666
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00111359	0.04237626749406666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.00111359	0.04237626749406666
NIEMANN-PICK DISEASE, TYPE A	0.00111359	0.04237626749406666
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.00111359	0.04237626749406666
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.00111359	0.04237626749406666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.00111359	0.04237626749406666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.00111359	0.04237626749406666
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.00111359	0.04237626749406666
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.00111359	0.04237626749406666
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.00111359	0.04237626749406666
TEMTAMY SYNDROME; TEMTYS	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.00111359	0.04237626749406666
SULFOCYSTEINURIA	0.00111359	0.04237626749406666
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.00111359	0.04237626749406666
#614111 PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD	0.00111359	0.04237626749406666
HEART AND BRAIN MALFORMATION SYNDROME	0.00111359	0.04237626749406666
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.00111359	0.04237626749406666
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.00111359	0.04237626749406666
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.00111359	0.04237626749406666
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.00111359	0.04237626749406666
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.00111359	0.04237626749406666
GLYCOGEN STORAGE DISEASE II	0.00111359	0.04237626749406666
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00111359	0.04237626749406666
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.00111359	0.04237626749406666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00111359	0.04237626749406666
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00111359	0.04237626749406666
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.00111359	0.04237626749406666
HYPOTONIA-CYSTINURIA SYNDROME	0.00111359	0.04237626749406666
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.00111359	0.04237626749406666
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.00111359	0.04237626749406666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00111359	0.04237626749406666
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00111359	0.04237626749406666
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00111359	0.04237626749406666
COMBINED SAPOSIN DEFICIENCY	0.00111359	0.04237626749406666
JOUBERT SYNDROME 5	0.00111359	0.04237626749406666
PYRUVATE CARBOXYLASE DEFICIENCY	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.00111359	0.04237626749406666
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00111359	0.04237626749406666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.00111359	0.04237626749406666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.00111359	0.04237626749406666
N-ACETYLASPARTATE DEFICIENCY; NACED	0.00111359	0.04237626749406666
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00111359	0.04237626749406666
ETHANOLAMINOSIS	0.00111359	0.04237626749406666
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.00111359	0.04237626749406666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00111359	0.04237626749406666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.00111359	0.04237626749406666
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.00111359	0.04237626749406666
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.00111359	0.04237626749406666
GOLDBERG-SHPRINTZEN SYNDROME	0.00111359	0.04237626749406666
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.00111359	0.04237626749406666
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.00111359	0.04237626749406666
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.00111359	0.04237626749406666
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.00111359	0.04237626749406666
